syndrome	score	normalized_score
EARLY-ONSET SCHIZOPHRENIA	8.07941569	100.0
SMITH-MAGENIS SYNDROME; SMS	5.13608621	63.57002049488557
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	4.00297619	49.54536743238174
PANDAS	2.6298768100000007	32.55033421853803
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	2.21471485	27.41181955449058
KLEINE-LEVIN HIBERNATION SYNDROME	2.0192308	24.99228753013945
NARCOLEPSY 1; NRCLP1	1.8373013	22.74052196960298
ISOTRETINOIN-LIKE SYNDROME	1.5030120500000002	18.602979567696934
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	1.4388815400000001	17.809227736368648
BRAIN-LUNG-THYROID SYNDROME	1.23225408	15.25177224790126
16P12.1P12.3 TRIPLICATION SYNDROME	1.22652468	15.180858703904615
TRICHOTHIODYSTROPHY	1.21912825	15.089312108410653
CITRULLINEMIA TYPE II	1.18751505	14.698031337461734
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.1714063399999999	14.498651696432269
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	1.09696395	13.577268358128011
SCHIZOPHRENIA	1.0894928	13.484796943279942
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	1.0714286	13.26121394305929
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	1.0666666999999999	13.202275274933898
PETERS PLUS SYNDROME	1.02729669	12.71498743741455
EHLERS-DANLOS SYNDROME, TYPE I	1.00728555	12.467306902487154
CHAR SYNDROME	1.0	12.377132683465133
MARFAN SYNDROME; MFS	1.0	12.377132683465133
TARDIVE DYSKINESIA	1.0	12.377132683465133
ATRESIA OF SMALL INTESTINE	1.0	12.377132683465133
KIFAFA SEIZURE DISORDER	1.0	12.377132683465133
BNAR SYNDROME	1.0	12.377132683465133
POSTERIOR MENINGOCELE	1.0	12.377132683465133
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	12.377132683465133
PLUMMER-VINSON SYNDROME	1.0	12.377132683465133
JUVENILE POLYPOSIS SYNDROME	1.0	12.377132683465133
EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC	0.95301205	11.795556591791108
CZEIZEL-LOSONCI SYNDROME	0.8678158	10.741071301407443
ISOLATED CLEFT LIP	0.8376065	10.367166787032838
NARCOLEPSY 3; NRCLP3	0.8373013	10.363389286137846
7Q11.23 MICRODUPLICATION SYNDROME	0.8260391	10.223995542430124
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 1; ASPG1	0.78320745	9.693862527328385
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.7462712499999999	9.23669827910538
CRI-DU-CHAT SYNDROME	0.7208867600000001	8.922511078273288
POSTENCEPHALITIC PARKINSONISM	0.70624938	8.741342283874989
FRONTOTEMPORAL DEMENTIA; FTD	0.70380691	8.711111508609603
FRONTOTEMPORAL LOBAR DEGENERATION WITH TDP43 INCLUSIONS, GRN-RELATED	0.6642504999999999	8.221516573558056
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.66145674	8.1869378353523
FRONTOTEMPORAL DEMENTIA, RIGHT TEMPORAL ATROPHY VARIANT	0.65936251	8.161017272772607
48,XXXY SYNDROME	0.63457391	7.854205481535262
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.6326430799999999	7.830307342436046
INHERITED CREUTZFELDT-JAKOB DISEASE	0.61823916	7.65202811343403
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 2; FASPS2	0.60900982	7.537795347673219
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.5641516299999999	6.9825795781031275
CLASSICAL EHLERS-DANLOS SYNDROME	0.56072712	6.9401939634572765
OBSESSIVE-COMPULSIVE DISORDER 1	0.55883255	6.9167446191891635
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.5528523299999999	6.842726642772851
XQ12-Q13.3 DUPLICATION SYNDROME	0.5436788100000001	6.729184768558431
MANGANESE POISONING	0.54086583	6.694368141862498
FOCAL DERMAL HYPOPLASIA	0.5366374799999999	6.642033292880366
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.5248744500000001	6.496440709810787
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.5248744500000001	6.496440709810787
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.5248744500000001	6.496440709810787
PSEUDOAMINOPTERIN SYNDROME	0.5177179500000001	6.407863759761569
MOMO SYNDROME	0.50704225	6.2757292043727
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.50671141	6.271634353795702
CUTIS LAXA	0.5059882400000001	6.2626835827530005
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.50297619	6.22540304025377
RESTRICTIVE DERMOPATHY	0.50297619	6.22540304025377
BULIMIA NERVOSA, SUSCEPTIBILITY TO, 1	0.5	6.1885663417325665
ZUNICH NEUROECTODERMAL SYNDROME	0.5	6.1885663417325665
GLUTATHIONE SYNTHETASE DEFICIENCY	0.5	6.1885663417325665
SEMANTIC DEMENTIA	0.5	6.1885663417325665
%613938 PARASOMNIA, SLEEPWALKING TYPE; PSMNSWPARASOMNIA, SLEEP TERRORS TYPE, INCLUDED; PSMNST, INCLUDED	0.5	6.1885663417325665
VASCULAR EHLERS-DANLOS SYNDROME	0.49632613	6.143094365280765
YOUNG-ONSET PARKINSON DISEASE	0.48612374999999997	6.016818154333634
X-LINKED ADRENOLEUKODYSTROPHY	0.46036826	5.698039037275975
LOEYS-DIETZ SYNDROME 3; LDS3	0.45728555	5.65988392658133
MUCOPOLYSACCHARIDOSIS TYPE 2	0.45332989	5.610924197910654
AUTISM	0.44987445000000004	5.568155758550901
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, SUSCEPTIBILITY TO, 2; ASPG2	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 1; ASPGX1	0.44987445000000004	5.568155758550901
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.44987445000000004	5.568155758550901
ASPERGER SYNDROME, X-LINKED, SUSCEPTIBILITY TO, 2; ASPGX2	0.44987445000000004	5.568155758550901
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.44283220000000006	5.48099289591077
16P13.2 MICRODELETION SYNDROME	0.43739893	5.413744592215679
CHILDHOOD ABSENCE EPILEPSY	0.42509113	5.261409318574126
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 1; FASPS1	0.40920604	5.06479745195534
WILLIAMS SYNDROME	0.40834412	5.054129353752809
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.4	4.950853073386054
CHILDHOOD DISINTEGRATIVE DISORDER	0.39708261	4.91474415026664
11Q22.2Q22.3 MICRODELETION SYNDROME	0.39168219	4.847902435380201
MONOSOMY 22Q13.3	0.38977241	4.824264834923973
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.3888886	4.813325801286998
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.38572324	4.7741477205760665
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.37870286	4.68725554582772
CHROMOSOME 17Q12 DELETION SYNDROME	0.36537525000000004	4.522297948504245
FRYNS MICROPHTHALMIA SYNDROME	0.3627448	4.4897405198370235
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.35937319	4.448009655510125
49,XXXXY SYNDROME	0.35921185	4.446012728922975
NORMAL PRESSURE HYDROCEPHALUS	0.3585671	4.438032572625311
SCHINZEL-GIEDION SYNDROME	0.35252334999999996	4.363228276969618
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.35215683999999997	4.358691934069801
GLOMUVENOUS MALFORMATION	0.35	4.331996439212796
KAPOSI SARCOMA	0.35	4.331996439212796
TRICHOTILLOMANIA; TTM	0.349462	4.325337541829093
DUPLICATION/INVERSION 15Q11	0.34603714999999996	4.282947718958127
FRYNS SYNDROME; FRNS	0.34556844999999997	4.277146556869386
POSTERIOR CORTICAL ATROPHY	0.34280516	4.242944949896494
OKAMOTO SYNDROME	0.34259226	4.240309858348184
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.34173636	4.229716270484407
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.34004440999999996	4.208774780840618
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.33888028	4.194366189369815
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.33882751	4.19371304807811
TEMPI SYNDROME	0.33870933999999997	4.192250442308905
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.33787845	4.18196640653354
ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3; FASPS3	0.33777744	4.180716192361182
FAMILIAL CHYLOMICRONEMIA SYNDROME	0.33777744	4.180716192361182
MAJOR AFFECTIVE DISORDER 1	0.33777744	4.180716192361182
DISTAL MONOSOMY 19P13.3	0.3376065	4.178600445300272
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.33630919	4.162543467298685
ANGELMAN SYNDROME	0.3357143	4.15518043483662
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.333333	4.1257067687774835
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.333333	4.1257067687774835
MAST SYNDROME	0.333333	4.1257067687774835
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.333333	4.1257067687774835
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.33228909	4.112786156197887
PRADER-WILLI SYNDROME	0.32897059	4.071712641387808
BETA-KETOTHIOLASE DEFICIENCY	0.3287949	4.06953810294665
CHROMOSOME 1P36 DELETION SYNDROME	0.32527733999999997	4.026000796104601
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.32455146999999995	4.0170166068036535
GITELMAN SYNDROME	0.31578484	3.908510864106808
PRKAR1B-RELATED NEURODEGENERATIVE DEMENTIA WITH INTERMEDIATE FILAMENTS	0.31154531	3.8560376387812774
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.309524	3.8310196167168624
OROFACIODIGITAL SYNDROME I; OFD1	0.3042001	3.7651250000233616
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.29911195	3.7021482923599893
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.29645794000000003	3.6692992584467463
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.29558179000000007	3.658455033646128
MYOCLONUS-DYSTONIA SYNDROME	0.29335655	3.630912942913574
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.29180599999999995	3.6117215798312263
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.291667	3.6100011583882257
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.291667	3.6100011583882257
2Q23.1 MICRODELETION SYNDROME	0.29056168	3.5963204660905377
DIGEORGE SYNDROME; DGS	0.28856152999999996	3.571564344153704
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.28706146000000005	3.55299777872922
TETRASOMY 9P	0.28326691000000004	3.5060321299051767
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.27878029	3.450500638864888
HYPERTRYPTOPHANEMIA; HYPTRP	0.27672768	3.4250952125474807
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.2763158	3.4199973191378152
SEVERE EARLY-ONSET OBESITY-INSULIN RESISTANCE SYNDROME DUE TO SH2B1 DEFICIENCY	0.27397014	3.390964774087518
1P21.3 MICRODELETION SYNDROME	0.27299465	3.378891004926125
CHRISTIANSON SYNDROME	0.27117585	3.3563794760014387
PLACENTAL INSUFFICIENCY	0.26894704999999997	3.3287933226765314
PALLISTER-HALL SYNDROME	0.26761467999999994	3.3123024024030627
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.2642857	3.271099175242462
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.2642857	3.271099175242462
LYSINURIC PROTEIN INTOLERANCE	0.2619048	3.2416304600363994
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.26148975	3.2364933311161277
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.26148975	3.2364933311161277
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.26148975	3.2364933311161277
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.26148975	3.2364933311161277
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.26148975	3.2364933311161277
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.26148975	3.2364933311161277
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.26148975	3.2364933311161277
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.26059142999999996	3.225374705283916
21Q22.11Q22.12 MICRODELETION SYNDROME	0.25934049000000003	3.209891654924863
ESOPHAGEAL ATRESIA	0.25925926	3.208886260436985
WILSON DISEASE	0.25918378	3.207952034462037
WILLIAMS-BEUREN SYNDROME; WBS	0.25823091	3.1961582360419434
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.25704225	3.181446033506416
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.25704225	3.181446033506416
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.25549451	3.1622894501669094
CHOANAL ATRESIA	0.25396799999999997	3.1433956333542725
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.25	3.0942831708662832
TUBERCULOSIS	0.25	3.0942831708662832
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.25	3.0942831708662832
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.25	3.0942831708662832
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.25	3.0942831708662832
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.25	3.0942831708662832
CORTICOSTEROID-SENSITIVE ASEPTIC ABSCESS SYNDROME	0.25	3.0942831708662832
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.25	3.0942831708662832
PRADER-WILLI-LIKE SYNDROME	0.24677551	3.054373230299777
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.24333569	3.01179812175254
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.24268294	3.0037189483934084
ADNP SYNDROME	0.24249757	3.001424599307874
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.23843362000000004	2.9511245509389066
SPASTIC PARAPLEGIA 16, X-LINKED	0.23803409999999997	2.9461796388892076
VELOCARDIOFACIAL SYNDROME	0.23588099	2.9195303107371124
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.23442700000000002	2.9015340835866814
CONGENITAL MYASTHENIC SYNDROME	0.23392839999999998	2.895362845230705
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.23392839999999998	2.895362845230705
PHELAN-MCDERMID SYNDROME	0.23079489	2.8565789761957405
ADENYLOSUCCINASE DEFICIENCY	0.22853189000000002	2.828569524933059
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.22664591	2.8052265002346974
NARCOLEPSY 7; NRCLP7	0.2261903	2.799587354812784
DYSTONIA 11, MYOCLONIC	0.22549955000000002	2.7910378504116804
STIFF PERSON SYNDROME AND RELATED DISORDERS	0.22247001000000002	2.7535408318618155
PAROXYSMAL HEMICRANIA	0.21970636999999998	2.7193348928924834
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.21857585000000002	2.705342296851173
ALCOHOL DEPENDENCE	0.2172414	2.6888256321417225
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.21708946999999998	2.6869451743731236
PITT-HOPKINS-LIKE SYNDROME	0.21585839	2.6717079338691634
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.21520013999999998	2.6635606862802725
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.21472004000000003	2.657618424878941
SCHIZOPHRENIA 10	0.2144928	2.6548058452479504
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.21424836000000003	2.6517803789348044
POPOV-CHANG SYNDROME; POPCHAS	0.2140845	2.649752261973292
HYDROCEPHALY-LOW INSERTION UMBILICUS SYNDROME	0.211111	2.6129488579390077
FAMILIAL CERVICAL ARTERY DISSECTION	0.20980392	2.5967709553511042
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.20966545000000003	2.595057093788425
STIFF-PERSON SYNDROME; SPS	0.20937055000000002	2.591407077360071
NARCOLEPSY TYPE 1	0.2089371	2.586042209198423
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.2083333	2.5785688964841467
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.20648184000000003	2.555653130406019
PEDIATRIC-ONSET GRAVES DISEASE	0.20586476999999997	2.5480155731410323
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.20570885	2.5460857306130267
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.20570885	2.5460857306130267
MALARIA	0.20537634000000002	2.5419702102244477
PITT-HOPKINS SYNDROME	0.20466515000000005	2.533167717231295
APNEA, OBSTRUCTIVE SLEEP	0.2036865	2.521054836330621
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.20307975	2.5135450110749287
46,XY OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.20301205	2.512707079192258
COFFIN-LOWRY SYNDROME; CLS	0.20301205	2.512707079192258
PORPHYRIA CUTANEA TARDA, TYPE I	0.2	2.475426536693027
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.2	2.475426536693027
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	2.475426536693027
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.2	2.475426536693027
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.2	2.475426536693027
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2	2.475426536693027
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	2.475426536693027
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	2.475426536693027
ROMANO-WARD SYNDROME	0.2	2.475426536693027
POLYARTERITIS NODOSA	0.2	2.475426536693027
ACUTE PROMYELOCYTIC LEUKEMIA	0.2	2.475426536693027
RADIATION PROCTITIS	0.2	2.475426536693027
CRANIOSYNOSTOSIS 4; CRS4	0.2	2.475426536693027
BENIGN SCHWANNOMA	0.2	2.475426536693027
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.19937039999999998	2.467633893955517
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.19918384	2.46532481608209
PROGRESSIVE NON-FLUENT APHASIA	0.19787205	2.4490886171992474
NON-DISTAL MONOSOMY 20Q	0.19709348	2.4394521530058815
HEREDITARY COPROPORPHYRIA	0.19663756000000002	2.4338091706728364
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.19216655000000002	2.378470886673737
WITTEVEEN-KOLK SYNDROME	0.19198088	2.376172824448398
MUCOLIPIDOSIS TYPE II	0.19047650000000002	2.3575529135820465
GITELMAN SYNDROME	0.1870752	2.315454572185777
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.1870752	2.315454572185777
GM2 GANGLIOSIDOSIS, AB VARIANT	0.18674431000000002	2.3113591027521454
HYPOPLASMINOGENEMIA	0.18633529999999998	2.3062967317132808
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.18629060000000003	2.3057434738823304
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.18587804	2.3006371640224397
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.18577807000000002	2.2993998220680734
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.18551289999999998	2.296117777794399
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.1852756	2.293180684208613
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.18500004	2.2897700415263573
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.18500004	2.2897700415263573
THORACOABDOMINAL SYNDROME	0.18469819	2.2860340040258533
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.18447792	2.2833076930096663
MONOSOMY X	0.18447792	2.2833076930096663
TURNER SYNDROME	0.18447792	2.2833076930096663
MOSAIC MONOSOMY X	0.18447792	2.2833076930096663
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.184019	2.2776275792785703
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.18381190000000003	2.275064275099825
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.18292109999999998	2.2640387253053937
RESTLESS LEGS SYNDROME, SUSCEPTIBILITY TO, 1; RLS1	0.182857	2.263245351100384
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.18125739000000002	2.2434467658885864
KERATODERMA HEREDITARIUM MUTILANS	0.1807515	2.2371852982353486
KOOLEN-DE VRIES SYNDROME	0.17932520000000002	2.219531793888922
KOOLEN-DE VRIES SYNDROME; KDVS	0.17898111	2.2152729463038683
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.17847085000000001	2.2089573905808035
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.17847064999999998	2.2089549151542665
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.17815645	2.2050660200651215
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.17592626	2.1774626625257847
INSULINOMA	0.17526790999999997	2.1693141772236255
ABLEPHARON-MACROSTOMIA SYNDROME	0.17401994	2.153867886948642
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.17395254999999998	2.1530337919771028
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.17395254999999998	2.1530337919771028
MULTIPLE SYSTEM ATROPHY	0.173611	2.1488063823090653
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.1729891	2.1411090434932185
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.17286090999999998	2.1395224188545248
2Q32Q33 MICRODELETION SYNDROME	0.17227555999999997	2.1322774642382583
XIA-GIBBS SYNDROME	0.17142839999999998	2.121792052514134
AURICULOCONDYLAR SYNDROME	0.17142839999999998	2.121792052514134
MELAS	0.171174	2.118643309959461
TRIGEMINAL NEURALGIA	0.17111144	2.117868996538783
TRISOMY 13	0.16964268999999998	2.0996900829099436
MCLEOD SYNDROME; MCLDS	0.16835655	2.083771357480432
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.16785700000000003	2.0775883608484076
SPINOCEREBELLAR ATAXIA TYPE 1	0.166667	2.062859572955084
PLEOCONIAL MYOPATHY WITH SALT CRAVING	0.166667	2.062859572955084
CEREBROOCULONASAL SYNDROME	0.166667	2.062859572955084
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.166667	2.062859572955084
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.166667	2.062859572955084
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.166667	2.062859572955084
PARAGANGLIOMAS 4	0.166667	2.062859572955084
SOLITARY BONE CYST	0.166667	2.062859572955084
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.166667	2.062859572955084
PARAGANGLIOMAS 3	0.166667	2.062859572955084
DERMATOLEUKODYSTROPHY	0.166667	2.062859572955084
ACUTE ADRENAL INSUFFICIENCY	0.166667	2.062859572955084
PARAGANGLIOMAS 1	0.166667	2.062859572955084
ADDISON DISEASE	0.166667	2.062859572955084
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	2.062859572955084
PERRY SYNDROME	0.16532722	2.0462769381284307
CHROMOSOME 16P13.2 DELETION SYNDROME	0.16485985000000003	2.0404922376261596
CARIBBEAN PARKINSONISM	0.16459617999999998	2.0372287590515104
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 6; CHTD6	0.1637426	2.026663886135558
LEPTIN DEFICIENCY OR DYSFUNCTION	0.16208779999999998	2.0061822069709594
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.16151198	1.9990552064291671
MYOTONIC DYSTROPHY 1	0.16025640000000002	1.9835147261744623
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.16009839999999997	1.981559139210474
SPINOCEREBELLAR ATAXIA TYPE 7	0.15945065	1.97354185151476
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.15908541999999998	1.9690213513447776
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.1589598	1.967466535937081
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.1571427	1.9449760481379565
EEC SYNDROME	0.15475539	1.9154279955113933
CHRONIC HICCUP	0.15454781999999997	1.912858874080286
LENNOX-GASTAUT SYNDROME	0.15430775	1.909887495836967
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.15238005000000002	1.8860280971630516
DRAVET SYNDROME	0.15188942	1.8799555045545628
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.1508941	1.8676362968520563
GOLDENHAR SYNDROME	0.14989924999999998	1.8553229064019108
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.1497326	1.8532602572402115
TRISOMY 18	0.14878518000000002	1.841533914193243
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.14810843999999998	1.8331578134210345
TUBEROUS SCLEROSIS COMPLEX	0.1475979	1.8268387921008187
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.14730143999999998	1.8231694673454781
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.14690621999999998	1.8182777769663192
KUFOR-RAKEB SYNDROME	0.14423214	1.7851803340001189
TONNE-KALSCHEUER SYNDROME; TOKAS	0.14410771	1.7836402473803155
3Q27.3 MICRODELETION SYNDROME	0.14320770000000002	1.77250070419387
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.14285699999999998	1.7681600437617784
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.14285699999999998	1.7681600437617784
PROLIDASE DEFICIENCY	0.14285699999999998	1.7681600437617784
ACROOTOOCULAR SYNDROME	0.14285699999999998	1.7681600437617784
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.14285699999999998	1.7681600437617784
PRIMARY PROGRESSIVE FREEZING GAIT	0.14285699999999998	1.7681600437617784
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.14285699999999998	1.7681600437617784
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.14285699999999998	1.7681600437617784
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.14285699999999998	1.7681600437617784
LARYNGOTRACHEOESOPHAGEAL CLEFT	0.14285699999999998	1.7681600437617784
SPINOCEREBELLAR ATAXIA TYPE 6	0.14285699999999998	1.7681600437617784
JUVENILE PRIMARY LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617784
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.14285699999999998	1.7681600437617784
8Q22.1 MICRODELETION SYNDROME	0.14285699999999998	1.7681600437617784
HUNTINGTON DISEASE-LIKE 1	0.14042569000000002	1.7380673972971432
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.13952592000000003	1.7269308246225419
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.13892525	1.7194962523335646
SYDENHAM CHOREA	0.13666975	1.691579629566009
ADRENOCORTICAL CARCINOMA	0.13663752	1.691180714579621
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.13552544000000002	1.6774163528649935
SMITH-MAGENIS SYNDROME	0.13547802	1.6768294292331434
17Q24.2 MICRODELETION SYNDROME	0.13526924999999998	1.6742454552428159
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.13486353	1.6692238049704808
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.1346876	1.6670462960174783
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.13339424	1.651038207689992
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.13310392999999998	1.647445002300655
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.13293112	1.645306110001626
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.13278162999999998	1.6434558524367742
DISTAL MONOSOMY 12Q	0.1325647	1.6407708810437505
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.1322581	1.636976052163
FG SYNDROME TYPE 1	0.13146738	1.6271892058075306
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.13115090000000001	1.6232720908558675
BRUNNER SYNDROME; BRNRS	0.13089283	1.6200779242242453
8Q24.3 MICRODELETION SYNDROME	0.13081235	1.6190818125858801
FAMILIAL ALZHEIMER-LIKE PRION DISEASE	0.13053441000000002	1.6156417123278384
PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	0.12992611	1.6081127025164863
CREUTZFELDT-JAKOB DISEASE; CJD	0.12961786	1.6042974513668082
HOLOPROSENCEPHALY	0.12914219	1.5984100206632639
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.12852298	1.590745976334336
USHER SYNDROME	0.12682065	1.5696760120532929
LUSCAN-LUMISH SYNDROME; LLS	0.12651676	1.5659147252021146
ROLANDIC EPILEPSY	0.12642465	1.5647746675106402
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.12602784999999997	1.5598634212618412
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.12510796	1.5484778206776486
NON-FUNCTIONING PARAGANGLIOMA	0.125	1.5471415854331416
ADULT-ONSET CERVICAL DYSTONIA, DYT23 TYPE	0.125	1.5471415854331416
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.125	1.5471415854331416
LYSINURIC PROTEIN INTOLERANCE; LPI	0.125	1.5471415854331416
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.12445218	1.5403611446064858
HSD10 DISEASE	0.12423601000000001	1.5376855798343014
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.1238095	1.5324066089734765
CARTILAGE-HAIR HYPOPLASIA	0.1237692	1.5319078105263328
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.12295130000000001	1.521784553704527
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.12295130000000001	1.521784553704527
JACOBSEN SYNDROME	0.12246513	1.5157671631078067
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.12237621000000001	1.514666588469593
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.12148964000000001	1.5036933939464132
CHILDHOOD APRAXIA OF SPEECH	0.12099711	1.4975972847858259
ARTHROCHALASIA EHLERS-DANLOS SYNDROME	0.12012195	1.4867653133465648
NON-24-HOUR SLEEP-WAKE SYNDROME	0.12003584	1.4856995184511916
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.11988292999999998	1.4838069310925626
MOHR-TRANEBJAERG SYNDROME	0.11965903	1.4810356910847349
KUFOR-RAKEB SYNDROME	0.1188844	1.4714479927941424
APLASIA CUTIS CONGENITA	0.11846393999999999	1.4662439035860526
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.11846393999999999	1.4662439035860526
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.11709924	1.4493528306129277
STEINERT MYOTONIC DYSTROPHY	0.11660550999999998	1.4432418688931203
POTOCKI-LUPSKI SYNDROME	0.11618595000000001	1.4380489191044459
ADULT-ONSET DYSTONIA-PARKINSONISM	0.11409354000000002	1.4121508829062368
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.11408718999999999	1.4120722881136964
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.11408718999999999	1.4120722881136964
GM2-GANGLIOSIDOSIS, AB VARIANT	0.1136364	1.4064928004713173
WIEDEMANN-STEINER SYNDROME	0.11290435000000001	1.397432120490387
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.11278827	1.39599538292849
CONGENITAL PULMONARY VENOUS RETURN ANOMALY	0.11265820000000001	1.394385489280352
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.1125	1.3924274268898276
HUNTINGTON DISEASE-LIKE SYNDROME DUE TO C9ORF72 EXPANSIONS	0.11232785	1.390296703498369
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.11189494999999999	1.384938642759697
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.11189494999999999	1.384938642759697
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.11189494999999999	1.384938642759697
POLAND SYNDROME	0.11174812	1.383121308367784
MEACHAM SYNDROME	0.11174812	1.383121308367784
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.11163829	1.381761927885159
SOMATOMAMMOTROPINOMA	0.11143637	1.3792627372537136
ACROMEGALY	0.11143637	1.3792627372537136
MUCKLE-WELLS SYNDROME	0.11111099999999999	1.3752355895924944
TRISOMY XQ28	0.11111099999999999	1.3752355895924944
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	0.11111099999999999	1.3752355895924944
DIAMOND-BLACKFAN ANEMIA 20; DBA20	0.11111099999999999	1.3752355895924944
ULNAR HEMIMELIA	0.11111099999999999	1.3752355895924944
NEURAL TUBE DEFECTS, FOLATE-SENSITIVE	0.11111099999999999	1.3752355895924944
BRACHYDACTYLY-MESOMELIA-INTELLECTUAL DISABILITY-HEART DEFECTS SYNDROME	0.11111099999999999	1.3752355895924944
DIABETIC EMBRYOPATHY	0.11111099999999999	1.3752355895924944
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.11111099999999999	1.3752355895924944
TOTAL ANOMALOUS PULMONARY VENOUS RETURN 1	0.11111099999999999	1.3752355895924944
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.11111099999999999	1.3752355895924944
ULNAR-MAMMARY SYNDROME	0.11111099999999999	1.3752355895924944
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.11111099999999999	1.3752355895924944
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.11111099999999999	1.3752355895924944
RING CHROMOSOME 22 SYNDROME	0.11077841000000001	1.371119079033301
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.11035434	1.3658703083762238
MYHRE SYNDROME	0.11011852000000001	1.3629515329468092
SAGLIKER SYNDROME	0.10937055	1.3536938090135575
CONGENITAL UNILATERAL PULMONARY HYPOPLASIA	0.10877193	1.3462846098465817
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.10782433000000001	1.3345560389157303
MEND SYNDROME	0.10672514000000001	1.3209512184413923
DEMENTIA, LEWY BODY; DLB	0.1055556	1.3064756666827724
NAGER SYNDROME	0.10549451	1.3057195476471395
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.10546448	1.305347862352655
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.1051948	1.302009997210578
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.10473934	1.296372708358567
EARLY-ONSET LAFORA BODY DISEASE	0.1046099	1.2947706123040195
HUNTINGTON DISEASE-LIKE 1	0.10444444	1.2927226919302133
48,XYYY SYNDROME	0.10438974000000001	1.2920456627724277
IDIOPATHIC HYPERSOMNIA	0.1036867	1.2833440434106442
HUNTINGTON DISEASE-LIKE 2	0.10330206	1.2785833030952762
HOLT-ORAM SYNDROME	0.10297619000000001	1.2745499668677156
MYASTHENIA GRAVIS	0.1029573	1.2743161628313249
NIEMANN-PICK DISEASE, TYPE C2	0.1029573	1.2743161628313249
22Q11.2 DELETION SYNDROME	0.10259352	1.2698136095037338
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.10256544000000001	1.2694660596179823
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.10250000000000001	1.2686561000551764
RAMOS-ARROYO SYNDROME	0.10218259000000002	1.2647274743701178
CHIARI MALFORMATION TYPE I	0.10083089	1.247997304121878
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.10059670000000001	1.245098703418737
MOWAT-WILSON SYNDROME; MOWS	0.10059529	1.2450812516616534
SPINOCEREBELLAR ATAXIA TYPE 29	0.1	1.2377132683465135
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.1	1.2377132683465135
PARTIAL ATRIOVENTRICULAR CANAL	0.1	1.2377132683465135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.1	1.2377132683465135
DESMOSTEROLOSIS	0.1	1.2377132683465135
METAPHYSEAL ANADYSPLASIA	0.1	1.2377132683465135
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	0.1	1.2377132683465135
49,XYYYY SYNDROME	0.0996504	1.233386222760374
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.09950134999999999	1.2315414111339034
FOCAL DERMAL HYPOPLASIA; FDH	0.09941058	1.2304179388002254
VACTERL WITH HYDROCEPHALUS	0.09878436	1.2226671307711858
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.0987216	1.2218903419239717
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.0981997	1.215430716376471
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.09782610000000001	1.2108066196059288
OCCIPITAL HORN SYNDROME	0.09777015	1.2101141190322886
ARTERIAL TORTUOSITY SYNDROME	0.09777015	1.2101141190322886
SCHIZOPHRENIA 1; SCZD1	0.09730530000000001	1.2043606089043801
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.09565324	1.1839128430833346
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.09565324	1.1839128430833346
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.09404759	1.1640394999901287
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0938597	1.1617139605302325
AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1	0.09166454	1.1345441739487971
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.09145210000000001	1.1319147758815218
RAYNAUD-CLAES SYNDROME; MRXSRC	0.09117673000000001	1.1285064848544761
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.09114580000000001	1.1281236601405766
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.0910714	1.1272028014689266
LAFORA DISEASE	0.09016666000000001	1.1160047144448884
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.08897250000000001	1.1012244376796017
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.08897250000000001	1.1012244376796017
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.08856062	1.0961265442699362
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.0885306	1.0957549827467783
15Q13.3 MICRODELETION SYNDROME	0.08845574	1.0948284305940943
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.08837385	1.0938148671986452
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.08807264000000001	1.0900867510630587
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.08787875000000002	1.087686948807062
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.08736964	1.0813856267865827
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.08731369000000001	1.080693126212943
47,XYY SYNDROME	0.08701528	1.07699966604887
NARCOLEPSY TYPE 2	0.08675089999999999	1.0737273997100154
HYDROXYKYNURENINURIA	0.0860457	1.064999045741636
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.08571430000000001	1.0608972639703356
NASU-HAKOLA DISEASE	0.08565881	1.06021045687773
HUNTINGTON DISEASE-LIKE 2	0.0851393	1.0537804126773431
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.08442411	1.0449284111534556
GLYCINE ENCEPHALOPATHY; GCE	0.08417805	1.0418828938853624
3Q29 MICRODELETION SYNDROME	0.08411932	1.0411559848828622
RETT SYNDROME, CONGENITAL VARIANT	0.08399551	1.0396235720853224
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.08391391000000001	1.0386135980583517
SMITH-LEMLI-OPITZ SYNDROME	0.08375534999999999	1.0366510799000614
49,XXXYY SYNDROME	0.08363451000000001	1.0351554271865917
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.08333330000000001	1.031427311051005
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.08333330000000001	1.031427311051005
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.08333330000000001	1.031427311051005
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.08333330000000001	1.031427311051005
SALT-AND-PEPPER SYNDROME	0.08307881	1.02827745455439
PHENYLKETONURIA	0.08224077999999999	1.0179050460516657
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.08222571000000001	1.017718522662126
METACHROMATIC LEUKODYSTROPHY	0.0820367	1.0153791208136242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.08184921	1.0130585322068013
NORRIE DISEASE	0.08182004999999999	1.0126976150177514
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.08122631	1.0053488162582709
CORNELIA DE LANGE SYNDROME 1	0.08005641000000001	0.9908688087318851
CUSHING DISEASE	0.07949597	0.9839321684907637
GLASS SYNDROME	0.07917999	0.9800212421054425
RABIES	0.07913175	0.979424169224792
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.07878154000000001	0.9750895735877159
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.07854884000000001	0.9722094148122735
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.07851787	0.9718260950130666
CRANIOPHARYNGIOMA	0.07769854	0.9616851388915231
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0776316	0.9608566136296919
1Q21.1 MICRODELETION SYNDROME	0.07714685	0.9548567985613823
17P11.2 MICRODUPLICATION SYNDROME	0.07709395	0.9542020482424267
EPISODIC ATAXIA, TYPE 6	0.07684937	0.9511748491307049
EPISODIC ATAXIA TYPE 6	0.07684937	0.9511748491307049
PRIMROSE SYNDROME; PRIMS	0.07586609	0.9390046621057073
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.07574086	0.9374546737797569
FAMILIAL THYROID DYSHORMONOGENESIS	0.07570210000000001	0.936974936116946
THYROID ECTOPIA	0.07570210000000001	0.936974936116946
THYROID HEMIAGENESIS	0.07570210000000001	0.936974936116946
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.07570210000000001	0.936974936116946
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.07570210000000001	0.936974936116946
FRAXE INTELLECTUAL DISABILITY	0.07411655	0.9173503733906778
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.07337811	0.9082106035318998
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0731092	0.9048822687819891
BILATERAL POLYMICROGYRIA	0.0731092	0.9048822687819891
PRADER-WILLI SYNDROME; PWS	0.07243153	0.8964946572763853
ACHONDROGENESIS TYPE 1A	0.07226801	0.894470748539985
ACHONDROGENESIS TYPE 2	0.07226801	0.894470748539985
ACHONDROGENESIS TYPE 1B	0.07226801	0.894470748539985
GLIOBLASTOMA	0.07204304	0.8916862650001861
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.0717884	0.8885345519336684
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.07165412	0.8868725505569327
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.07142860000000001	0.8840812595941577
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.07142860000000001	0.8840812595941577
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.07142860000000001	0.8840812595941577
ALZHEIMER DISEASE 4	0.07142860000000001	0.8840812595941577
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.07142860000000001	0.8840812595941577
POSTPOLIOMYELITIS SYNDROME	0.07142860000000001	0.8840812595941577
ATHYREOSIS	0.07142860000000001	0.8840812595941577
AREGENERATIVE ANEMIA	0.07111113999999999	0.8801520150524647
DARIER-WHITE DISEASE; DAR	0.0704545	0.8720246946471943
KLEEFSTRA SYNDROME	0.07028443	0.8699197156917172
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.07014978	0.8682531347758888
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.06978555	0.8637450117385903
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.069264	0.8572897181875292
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.069264	0.8572897181875292
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.06902731999999999	0.8543602984240064
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.06890754	0.852877765471181
PSEUDOTRISOMY 13 SYNDROME	0.06887165	0.8524335501791716
CORNELIA DE LANGE SYNDROME	0.06831264	0.8455146092377877
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.06795380000000001	0.8410731989456531
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.0676425	0.8372201975412903
MYOCLONIC EPILEPSY OF LAFORA	0.0676038	0.8367412025064404
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.06759543	0.8366376059058797
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.06744533	0.8347797982900914
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.06744165	0.8347342504418164
CENTRAL DIABETES INSIPIDUS	0.06741319	0.8343819972456449
TRIPLOIDY	0.06737196000000001	0.8338716880651058
ARNOLD-CHIARI MALFORMATION TYPE I	0.06704545	0.8298304304726275
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.06694444	0.8285802163002706
HEPATOCELLULAR CARCINOMA	0.0666667	0.825142591468765
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.06658700000000001	0.8241561339938929
SUSAC SYNDROME	0.06646764	0.8226787994367945
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.06586575	0.8152291270459436
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.06567676	0.8128899727400956
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.06565465000000001	0.8126163143364643
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.06553491	0.811134276468946
POLYDACTYLY-MYOPIA SYNDROME	0.06551205	0.8108513352158021
PERLMAN SYNDROME	0.06551205	0.8108513352158021
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.06551205	0.8108513352158021
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.06551205	0.8108513352158021
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.0652947	0.8081611654270509
13Q12.3 MICRODELETION SYNDROME	0.06512113	0.8060128665071818
PORPHYRIA VARIEGATA	0.06492615	0.8035995731765598
15Q24 MICRODELETION SYNDROME	0.0646014	0.7995800993376045
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.0644928	0.7982359427281802
NEUROLEPTIC MALIGNANT SYNDROME	0.06429791	0.7958237633394996
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.06428798	0.7957008584119528
NOCARDIOSIS	0.06419984000000001	0.7946099379372323
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.06398344	0.7919315264245305
ACUTE INTERMITTENT PORPHYRIA	0.06386335	0.790445156560573
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.06356284	0.7867257044178649
PAGOD SYNDROME	0.06348569000000001	0.7857708086313357
PARKINSONIAN-PYRAMIDAL SYNDROME	0.06280198000000001	0.7773084392443238
SCHAAF-YANG SYNDROME; SHFYNG	0.0627914	0.7771774891805326
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.0625	0.7735707927165708
HADDAD SYNDROME	0.0625	0.7735707927165708
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.0625	0.7735707927165708
DYSTONIA 12; DYT12	0.06247675	0.7732830243816803
RAPID-ONSET DYSTONIA-PARKINSONISM	0.06247675	0.7732830243816803
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0622606	0.7706077071521493
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.062048200000000005	0.7679788041701814
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0616699	0.7632965348760264
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.06143066	0.7603354296528342
MARFAN SYNDROME	0.06117741000000001	0.7572009208007469
BENIGN OCCIPITAL EPILEPSY	0.060931940000000004	0.7541627060409366
FRASER SYNDROME	0.06086301	0.7533095502850653
PERRY SYNDROME	0.060733920000000004	0.7517117862269569
RHEUMATOID ARTHRITIS	0.0607197	0.7515357834001979
HOLT-ORAM SYNDROME	0.0604441	0.7481246456326349
RING CHROMOSOME 12 SYNDROME	0.0604441	0.7481246456326349
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.060294940000000005	0.7462784725215693
AICARDI SYNDROME; AIC	0.0600359	0.7430723000712445
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.05998167000000001	0.7424010881658202
SCHISIS ASSOCIATION	0.059706859999999994	0.738999728333077
SPINOCEREBELLAR ATAXIA 12	0.05937055	0.7348371748403009
ALG11-CDG	0.0588235	0.7280662644058113
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0588235	0.7280662644058113
SPINOCEREBELLAR ATAXIA TYPE 40	0.0588235	0.7280662644058113
BUTYRYLCHOLINESTERASE	0.0588235	0.7280662644058113
MULTIFOCAL MOTOR NEUROPATHY	0.0588235	0.7280662644058113
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.0588235	0.7280662644058113
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.0588235	0.7280662644058113
16P13.11 MICRODELETION SYNDROME	0.05818969	0.7202215139397043
TURNPENNY-FRY SYNDROME; TPFS	0.05800918	0.717987317719012
INIENCEPHALY	0.0580085	0.7179789012687873
KLEEFSTRA SYNDROME	0.057884269999999995	0.7164412900755204
178610 PULMONARY NODULAR LYMPHOID HYPERPLASIA, FAMILIAL	0.05736720000000001	0.7100414460788811
N-ACETYLASPARTATE DEFICIENCY; NACED	0.05710565000000001	0.7068042070255208
ALZHEIMER DISEASE 9, SUSCEPTIBILITY TO; AD9	0.05707604	0.7064377201267634
ALEXANDER DISEASE	0.05690614	0.7043348452838426
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.056905250000000004	0.7043238296357544
GANGLIOCYTOMA	0.05686524	0.7038286205570888
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.05677989	0.7027722322825551
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.056711410000000004	0.7019246462363915
OTOPALATODIGITAL SYNDROME TYPE 2	0.05640026	0.6980735014019313
HALLERMANN-STREIFF SYNDROME; HSS	0.0563492	0.6974415250071136
2Q37 MICRODELETION SYNDROME	0.056280479999999994	0.6965909684491057
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.0559079	0.6919794963539003
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.05552759	0.6872723490230518
NIEMANN-PICK DISEASE TYPE B	0.05536342	0.6852403951504074
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.05526076	0.6839697587091228
9P13 MICRODELETION SYNDROME	0.05519248	0.6831246480894958
MENINGIOMA	0.05517834	0.6829496354333515
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.05489349	0.6794240091884666
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.05482505	0.6785769182276102
FILIPPI SYNDROME	0.0546099	0.6759139781307626
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0546099	0.6759139781307626
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.0546099	0.6759139781307626
MIETENS SYNDROME	0.0546099	0.6759139781307626
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0546099	0.6759139781307626
HYPERTRICHOSIS CUBITI	0.0546099	0.6759139781307626
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.0546099	0.6759139781307626
NEUHAUSER-EICHNER-OPITZ SYNDROME	0.0546099	0.6759139781307626
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.0546099	0.6759139781307626
BECKWITH-WIEDEMANN SYNDROME	0.054553399999999995	0.6752146701341468
NEUROFIBROMATOSIS TYPE 1	0.054319120000000005	0.6723149554890647
NEUROCUTANEOUS MELANOCYTOSIS	0.054226430000000006	0.6711677190606343
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.05403794	0.6688347533211279
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 5; IBGC5	0.05394997	0.6677459369589636
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.05374004	0.6651476054947236
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.05363528	0.6638509770748038
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.05360379	0.6634612211666016
1P36 DELETION SYNDROME	0.05301575	0.6561829720634167
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.053012050000000005	0.6561371766724879
SMITH-FINEMAN-MYERS SYNDROME	0.053012050000000005	0.6561371766724879
LATHOSTEROLOSIS	0.052807440000000004	0.6536046915541242
LATERAL MENINGOCELE SYNDROME	0.052740050000000004	0.6527705965825854
LATERAL MENINGOCELE SYNDROME	0.052740050000000004	0.6527705965825854
ATRIAL SEPTAL DEFECT WITH ATRIOVENTRICULAR CONDUCTION DEFECTS	0.0526316	0.6514282965430636
PRIMARY PULMONARY HYPOPLASIA	0.0526316	0.6514282965430636
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.0526316	0.6514282965430636
ATRIAL SEPTAL DEFECT 1	0.0526316	0.6514282965430636
PULMONIC STENOSIS, ATRIAL SEPTAL DEFECT, AND UNIQUE ELECTROCARDIOGRAPHICABNORMALITIES	0.0526316	0.6514282965430636
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.0526316	0.6514282965430636
DOHLE BODIES AND LEUKEMIA	0.0526316	0.6514282965430636
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0526316	0.6514282965430636
MONOSOMY 18Q	0.0526316	0.6514282965430636
IMMUNODEFICIENCY, OVARIAN DYSGENESIS, AND PULMONARY FIBROSIS	0.0526316	0.6514282965430636
CARDIAC SEPTAL DEFECTS WITH COARCTATION OF THE AORTA	0.0526316	0.6514282965430636
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.0526316	0.6514282965430636
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.05260747	0.6511296363314115
CRANIORACHISCHISIS	0.05251399	0.6499726219681612
PARKINSON DISEASE, LATE-ONSET; PD	0.052499420000000005	0.6497922871449632
OCULOCEREBRORENAL SYNDROME OF LOWE	0.05233408	0.647745852027079
RETT SYNDROME; RTT	0.05216591	0.6456643896237008
1Q21.1 MICRODUPLICATION SYNDROME	0.05199953	0.6436050822878258
HARTNUP DISEASE	0.05131218	0.635097660137846
WAARDENBURG SYNDROME TYPE 1	0.05094901	0.630602656861192
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.05083084	0.6291400510919869
AMYOTROPHIC LATERAL SCLEROSIS	0.050723950000000004	0.6278170593794513
SIRENOMELIA	0.0505051	0.6251083238916749
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.05038388	0.6236079678677853
TRANSKETOLASE DEFICIENCY	0.05038388	0.6236079678677853
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.050370040000000005	0.6234366683514462
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.05019384	0.6212558175726196
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.05	0.6188566341732568
LOEYS-DIETZ SYNDROME 5	0.049976049999999994	0.6185602018454877
LYME DISEASE	0.04992179	0.6178886186260829
OROMANDIBULAR DYSTONIA	0.04989894	0.6176058011442658
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.04977471000000001	0.616068189950999
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.049554930000000004	0.6133479437298269
ERYTHERMALGIA, PRIMARY	0.0494995	0.6126618792651823
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.04927881	0.6099303698532684
BAKER-GORDON SYNDROME; BAGOS	0.0492035	0.6089982479908768
USHER SYNDROME TYPE 2	0.04886335	0.6047881663085961
USHER SYNDROME TYPE 1	0.04886335	0.6047881663085961
USHER SYNDROME TYPE 3	0.04886335	0.6047881663085961
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.0488247	0.6043097901303801
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.04875074	0.603394377397111
MECKEL SYNDROME, TYPE 4; MKS4	0.04843069	0.5994330760817681
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.04843069	0.5994330760817681
ARTERIAL TORTUOSITY SYNDROME	0.04831558	0.5980083443385743
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.047946039999999995	0.5934344987267266
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.04778246	0.5914098473623653
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.047619	0.5893866812539262
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.047225090000000004	0.5845112049185825
MICROPHTHALMIA, SYNDROMIC 1	0.04704105	0.5822333174195176
FIBULAR HEMIMELIA	0.04703554	0.5821651194184316
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.046811109999999996	0.5793873195302816
JOUBERT SYNDROME 1	0.04680284	0.5792849606429893
COFFIN-SIRIS SYNDROME 1; CSS1	0.04661342000000001	0.5769404841700875
FETAL HYDANTOIN SYNDROME	0.0465368	0.5759921482638802
WHITE FORELOCK WITH MALFORMATIONS	0.04645449	0.5749733864727042
DESANTO-SHINAWI SYNDROME	0.04618581000000001	0.5716478984633109
CHOREOACANTHOCYTOSIS	0.04600717	0.5694368474807366
LYNCH SYNDROME	0.04584316	0.5674068739493215
FAMILIAL COLORECTAL CANCER TYPE X	0.04584316	0.5674068739493215
FACIOMANDIBULAR MYOCLONUS, NOCTURNAL	0.0454545	0.562596377560566
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.0454545	0.562596377560566
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.0454545	0.562596377560566
MICROTRIPLICATION 11Q24.1	0.0454545	0.562596377560566
HUMERO-RADIAL SYNOSTOSIS	0.0454545	0.562596377560566
PHOCOMELIA, SCHINZEL TYPE	0.0454545	0.562596377560566
CLEFT LIP/PALATE-DEAFNESS-SACRAL LIPOMA SYNDROME	0.0454545	0.562596377560566
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0454545	0.562596377560566
WILDERVANCK SYNDROME	0.0454545	0.562596377560566
LITHIUM TRANSPORT	0.0454545	0.562596377560566
ACROMELIC FRONTONASAL DYSPLASIA	0.0454545	0.562596377560566
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0454545	0.562596377560566
MAJOR AFFECTIVE DISORDER 2	0.0454545	0.562596377560566
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.0454545	0.562596377560566
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.0454545	0.562596377560566
MUSCLE-EYE-BRAIN DISEASE	0.0454545	0.562596377560566
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.0454545	0.562596377560566
TYPHOID	0.04537634	0.5616289808700263
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.045321700000000006	0.5609526943402018
16P13.11 MICRODUPLICATION SYNDROME	0.04522226	0.559721912266158
SILVER-RUSSELL SYNDROME	0.04508845	0.5580657281417836
MARSHALL-SMITH SYNDROME; MRSHSS	0.04508035	0.5579654733670474
SILVER-RUSSELL SYNDROME; SRS	0.0448255	0.5548111611026663
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.04471564	0.5534514093060608
TRISOMY 18P	0.04447549	0.5504790408921267
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.04415663	0.5465324683646771
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.04385976	0.5428580689849367
HEREDITARY HYPEREKPLEXIA	0.043777979999999994	0.5418458670740829
CAUDAL DUPLICATION	0.04374206	0.5414012804680929
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.04374206	0.5414012804680929
CLOACAL EXSTROPHY	0.04374206	0.5414012804680929
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.043478300000000004	0.5381366879515022
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.043478300000000004	0.5381366879515022
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.043478300000000004	0.5381366879515022
LICHTENSTEIN SYNDROME	0.043478300000000004	0.5381366879515022
NEONATAL LUPUS ERYTHEMATOSUS	0.043478300000000004	0.5381366879515022
JUVENILE XANTHOGRANULOMA	0.043478300000000004	0.5381366879515022
FASCIAL DYSTROPHY, CONGENITAL	0.043478300000000004	0.5381366879515022
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.043478300000000004	0.5381366879515022
HEMOSIDEROSIS, PULMONARY, WITH DEFICIENCY OF GAMMA-A GLOBULIN	0.043478300000000004	0.5381366879515022
250230 METAPHYSEAL CHONDRODYSPLASIA, KAITILA TYPE	0.043478300000000004	0.5381366879515022
SLC35A2-CDG	0.043478300000000004	0.5381366879515022
CHONDROITIN-6-SULFATURIA, DEFECTIVE CELLULAR IMMUNITY, NEPHROTIC SYNDROME	0.043478300000000004	0.5381366879515022
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.043478300000000004	0.5381366879515022
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.043478300000000004	0.5381366879515022
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.04344151	0.5376813332400775
KAGAMI-OGATA SYNDROME	0.04340197	0.5371919414137732
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.043172220000000004	0.5343482951797471
ISOLATED HEMIHYPERPLASIA	0.042989360000000004	0.5320850126972487
ACALVARIA	0.04253157	0.5264188851260851
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.042519839999999996	0.5262737013597081
48,XXYY SYNDROME	0.042432040000000004	0.5251869891101
FANCONI ANEMIA	0.04238043000000001	0.5245482052923064
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.04237233	0.5244479505175702
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0422414	0.522827412535324
WOLFRAM SYNDROME	0.04214738	0.5216637145204247
OGDEN SYNDROME	0.04198156	0.5196113383788525
LATHOSTEROLOSIS	0.04183574	0.5178065048909497
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0417293	0.5164890828881216
CHROMOSOME 10Q26 DELETION SYNDROME	0.04138427	0.5122186007983457
CHARGE SYNDROME	0.04129393	0.5111004506317214
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.041259699999999996	0.5106767813799664
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.041229600000000005	0.5103042296861942
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.04108196	0.5084768698168073
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.040935700000000005	0.5066665903905238
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.04086651	0.5058102165801548
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.04083021	0.505360926663745
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.0408086	0.5050934568264552
GALLOWAY-MOWAT SYNDROME	0.040661459999999996	0.5032722855234101
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.0406015	0.5025301526477096
WILSON DISEASE	0.0406015	0.5025301526477096
TRISOMY 20P	0.04055786000000001	0.5019900145774033
WHITE-SUTTON SYNDROME; WHSUS	0.04025574	0.4982506352510747
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.04019134	0.49745354790625956
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.04006544	0.49589526690141134
DELAYED SLEEP PHASE DISORDER, SUSCEPTIBILITY TO; DSPD	0.04	0.4950853073386054
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.04	0.4950853073386054
MERCURY POISONING	0.04	0.4950853073386054
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.04	0.4950853073386054
BUERGER DISEASE	0.04	0.4950853073386054
ISOLATED SPINA BIFIDA	0.03997731	0.4948044701980176
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.03997731	0.4948044701980176
TRISOMY 8Q	0.03997731	0.4948044701980176
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.03997337	0.49475570429524474
NOVELTY SEEKING PERSONALITY TRAIT	0.039968699999999996	0.49469790308561284
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	0.49469790308561284
COSTELLO SYNDROME; CSTLO	0.03995095	0.4944782089804814
ROSSELLI-GULIENETTI SYNDROME	0.039721099999999995	0.4916333250331869
DIABETES MELLITUS, INSULIN-DEPENDENT; IDDM	0.039638999999999994	0.49061716243987435
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.03961949	0.49037568458122005
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.03954365	0.489437002838506
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.03950779	0.488993158860477
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.039504479999999995	0.4889521905512947
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.03949072	0.48878188120557026
SIALURIA	0.03945568	0.48834818647634165
MAN1B1-CDG	0.03943095	0.48804209998507947
ATYPICAL TERATOID RHABDOID TUMOR	0.03924263	0.48571123835812935
BENIGN PAROXYSMAL TORTICOLLIS OF INFANCY	0.03924263	0.48571123835812935
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.03921476	0.4853662876702412
SPINOCEREBELLAR ATAXIA TYPE 10	0.03915746	0.48465707796747864
VACTERL/VATER ASSOCIATION	0.03909275	0.4838561537115317
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.03896951	0.4823307958796213
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.03896951	0.4823307958796213
MYOPATHY AND DIABETES MELLITUS	0.038888900000000004	0.48133307521400726
ACRORENAL-MANDIBULAR SYNDROME	0.038852170000000005	0.48087846313054367
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.038364	0.4748363182684564
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.03829731	0.4740108872897961
248100 MACROSOMIA ADIPOSA CONGENITA	0.0380987	0.4715526649675331
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.03785723	0.46856395873845674
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.03721213	0.46057947044435343
DUBOWITZ SYNDROME	0.03714035	0.4596910398603343
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.03680355	0.45552242157254325
PITUITARY APOPLEXY	0.03680355	0.45552242157254325
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.0367747	0.45516534129462527
OBESITY DUE TO LEPTIN RECEPTOR GENE DEFICIENCY	0.0367747	0.45516534129462527
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.03676474	0.4550420650530979
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.036697350000000004	0.45420797008155933
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.0366251	0.4533137222451789
XP22.13P22.2 DUPLICATION SYNDROME	0.03659392	0.4529278032481085
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0365316	0.45215646033927487
HYPERPROLINEMIA, TYPE I	0.036450750000000004	0.45115576916181677
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.03630305	0.449327666664469
CYCLIC VOMITING SYNDROME	0.036199550000000004	0.44804663343173035
SAETHRE-CHOTZEN SYNDROME	0.03613173	0.44720721629313775
THUMBS, CONGENITAL CLASPED	0.0361093	0.4469295972070475
17Q21.31 MICRODUPLICATION SYNDROME	0.03598867	0.4454365436914412
CLASSIC HOMOCYSTINURIA	0.035857700000000006	0.4438155106238878
MUCOPOLYSACCHARIDOSIS, TYPE II	0.03585695	0.4438062277743751
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.03585695	0.4438062277743751
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.03579522	0.4430421873738249
4Q21 MICRODELETION SYNDROME	0.03572607	0.4421863086487632
SIMPSON-GOLABI-BEHMEL SYNDROME	0.03564587	0.44119366260754933
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.03561658	0.44083113639125066
PELVIS-SHOULDER DYSPLASIA	0.035590300000000005	0.44050586534432923
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.0355392	0.4398733938642041
HURLER SYNDROME	0.03550032	0.43939217094547095
PARKINSON DISEASE 14, AUTOSOMAL RECESSIVE; PARK14	0.03549958	0.43938301186728523
CUSHING SYNDROME	0.035376540000000005	0.4378601294619118
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.03531276	0.4370707159393602
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.03531276	0.4370707159393602
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.03523429	0.43609948233768875
8P INVERTED DUPLICATION/DELETION SYNDROME	0.03523403	0.43609626428319104
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.03523403	0.43609626428319104
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.03513074	0.43481783024831594
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.03511018	0.4345633564003438
SMITH-MAGENIS SYNDROME	0.03502418	0.4334989229895659
COFFIN-LOWRY SYNDROME	0.0349178	0.43218224361469887
HELSMOORTEL-VAN DER AA SYNDROME	0.03474521	0.4300460742848596
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.034604590000000005	0.4283056018869108
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.03455964	0.427749249772789
AMISH LETHAL MICROCEPHALY	0.03448921	0.42687752831789255
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.03448921	0.42687752831789255
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.0344828	0.42679819089739157
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.0344828	0.42679819089739157
ISOLATED ANORECTAL MALFORMATION	0.0344828	0.42679819089739157
CEREBROCOSTOMANDIBULAR SYNDROME	0.0344828	0.42679819089739157
SPONDYLOCOSTAL DYSOSTOSIS 4, AUTOSOMAL RECESSIVE; SCDO4	0.0344828	0.42679819089739157
DIAPHANOSPONDYLODYSOSTOSIS	0.0344828	0.42679819089739157
HEMIHYPERPLASIA, ISOLATED	0.0344828	0.42679819089739157
WAARDENBURG SYNDROME	0.0344828	0.42679819089739157
PHAVER SYNDROME	0.0344828	0.42679819089739157
LUMBAR SYNDROME	0.0344828	0.42679819089739157
TIBIAL HEMIMELIA	0.0344828	0.42679819089739157
CHIARI MALFORMATION TYPE II	0.0344828	0.42679819089739157
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.03437055	0.42540885775367254
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.03436482	0.42533793678339626
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.03417805	0.4230262597121055
MYOCLONIC-ASTASTIC EPILEPSY	0.03417805	0.4230262597121055
15Q11Q13 MICRODUPLICATION SYNDROME	0.03413024	0.42243450899850904
ADIPOSIS DOLOROSA	0.034041470000000004	0.4213357909301979
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.03398416	0.4206264574561085
CEREBROFACIOARTICULAR SYNDROME	0.0338018	0.41836936353995174
DISTAL MONOSOMY 10Q	0.033755860000000006	0.4178007580644735
DISTAL MONOSOMY 15Q	0.03360602	0.41594616850318294
22Q11.2 MICRODUPLICATION SYNDROME	0.033561839999999996	0.4153993467812274
POTOCKI-LUPSKI SYNDROME (17P11.2 DUPLICATION SYNDROME)	0.03335805	0.4128770109116641
NEU-LAXOVA SYNDROME	0.03327231	0.41181579555538383
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.033231	0.4113044962042298
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.033231	0.4113044962042298
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.033196630000000005	0.41087909415389917
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.0331548	0.4103613586937498
DERMOCHONDROCORNEAL DYSTROPHY	0.0331536	0.41034650613452966
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.03302721	0.4087821603346665
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.03301584	0.40864143233605543
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.03289503	0.4071461509365661
HURLER-SCHEIE SYNDROME	0.032844899999999996	0.40652568527514393
ACROCALLOSAL SYNDROME; ACLS	0.0327912	0.4058610332500419
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.03274593	0.4053007204534614
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.03251714	0.4024689562668114
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.03251714	0.4024689562668114
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.03250586	0.40232934221014194
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.03231579	0.3999768206009957
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	0.3992627838164866
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0322581	0.3992627838164866
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	0.3992627838164866
NETHERTON SYNDROME; NETH	0.0322581	0.3992627838164866
HERNIA, HIATUS	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.0322581	0.3992627838164866
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.0322581	0.3992627838164866
PRIMARY BILIARY CHOLANGITIS	0.0322581	0.3992627838164866
AICARDI SYNDROME	0.0322581	0.3992627838164866
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.0322581	0.3992627838164866
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	0.3992627838164866
GASTROCUTANEOUS SYNDROME	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.0322581	0.3992627838164866
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.0322581	0.3992627838164866
PROGRESSIVE HEMIFACIAL ATROPHY	0.0322581	0.3992627838164866
FETAL AKINESIA DEFORMATION SEQUENCE	0.0322581	0.3992627838164866
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	0.3992627838164866
HYPER-BETA-ALANINEMIA	0.0322581	0.3992627838164866
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	0.3992627838164866
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.0322581	0.3992627838164866
OBESITY-HYPOVENTILATION SYNDROME	0.0322581	0.3992627838164866
GASTROCUTANEOUS SYNDROME	0.0322581	0.3992627838164866
SPINOCEREBELLAR ATAXIA TYPE 34	0.0322581	0.3992627838164866
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	0.3992627838164866
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0322581	0.3992627838164866
137210 GASTRIC VOLVULUS, INTRATHORACIC	0.0322581	0.3992627838164866
SANDIFER SYNDROME	0.0322581	0.3992627838164866
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0322581	0.3992627838164866
ROWLEY-ROSENBERG SYNDROME	0.0322581	0.3992627838164866
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	0.3992627838164866
THROMBOCYTOPENIA 1	0.0322581	0.3992627838164866
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.0322581	0.3992627838164866
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.0322581	0.3992627838164866
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.0322581	0.3992627838164866
ESOPHAGEAL RING, LOWER	0.0322581	0.3992627838164866
DESMOID TUMOR	0.0322581	0.3992627838164866
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	0.3992627838164866
INFANTILE MYOFIBROMATOSIS	0.0322581	0.3992627838164866
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0322581	0.3992627838164866
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	0.3992627838164866
FLUSHING OF EARS AND SOMNOLENCE	0.0322581	0.3992627838164866
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.0322581	0.3992627838164866
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.0322498	0.3991600536152139
TYSHCHENKO SYNDROME	0.03221285	0.3987027185625599
ALSTRÖM SYNDROME	0.03216114	0.3980626970314979
GABRIELE-DE VRIES SYNDROME	0.03213874	0.39778544925938825
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.032103440000000004	0.39734853647566193
WHIPPLE DISEASE	0.03209902	0.397293829549201
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.03204225	0.39659117972676067
MILLER-DIEKER SYNDROME	0.03198656	0.3959018972076185
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.03185503	0.39427393294576235
6Q16 MICRODELETION SYNDROME	0.03176756	0.3931913051499396
NIPAH VIRUS DISEASE	0.03169214	0.3922578218029527
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0316284	0.39146890336570866
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.031622	0.3913896897165345
FRAGILE X SYNDROME	0.03151734	0.39009429900988296
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.03150169	0.3899005968833868
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.031432800000000004	0.3890479362128229
OBESITY DUE TO SIM1 DEFICIENCY	0.03140669	0.3887247692784576
GAUCHER DISEASE, PERINATAL LETHAL	0.031130659999999998	0.3853083093438407
FATCO SYNDROME	0.031130659999999998	0.3853083093438407
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.03105588	0.3843827473617712
FAMILIAL GESTATIONAL HYPERTHYROIDISM	0.03105588	0.3843827473617712
CLASSIC PHENYLKETONURIA	0.03103567	0.38413260551023837
C SYNDROME	0.030878640000000002	0.38218902436495383
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.03078985	0.38109005875398894
HUNTINGTON DISEASE; HD	0.03076024	0.3807235718552316
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.03076024	0.3807235718552316
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03076024	0.3807235718552316
MOSAIC TRISOMY 9	0.030753990000000002	0.38064621477595995
NEPHRONOPHTHISIS 11; NPHP11	0.030717499999999995	0.3801945732043402
XQ28 (MECP2) DUPLICATION	0.0306985	0.3799594076833544
FRYNS SYNDROME	0.030689390000000004	0.3798466520046081
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.030414699999999996	0.376446777427787
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0303993	0.3762561695844617
CRANIOFACIOFRONTODIGITAL SYNDROME	0.030012849999999997	0.3714730266589365
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.029935989999999996	0.37052172024088537
CHROMOSOME 15Q25 DELETION SYNDROME	0.02990666	0.3701586989392794
ADAMS-OLIVER SYNDROME 5; AOS5	0.02980395	0.36888744364136067
MENTAL RETARDATION, X-LINKED 21	0.02976955	0.36846167027704946
MECKEL SYNDROME, TYPE 1; MKS1	0.02972996	0.3679716595941111
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.02967062	0.36723720054067427
HARTNUP DISORDER	0.029592100000000003	0.36626534808236866
TIMOTHY SYNDROME; TS	0.02956065	0.3658760872594736
BRONCHOPULMONARY DYSPLASIA	0.02953864	0.3656036665691106
2Q23.1 MICRODUPLICATION SYNDROME	0.02952962	0.3654920248323057
HAIRY EARS, Y-LINKED	0.0294118	0.3640337510595398
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	0.3640337510595398
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.0294118	0.3640337510595398
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.0294118	0.3640337510595398
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	0.3640337510595398
OSSIFIED EAR CARTILAGES	0.0294118	0.3640337510595398
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	0.3640337510595398
EAR MALFORMATION	0.0294118	0.3640337510595398
EAR FOLDING	0.0294118	0.3640337510595398
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	0.3640337510595398
OSTEOMA OF MIDDLE EAR	0.0294118	0.3640337510595398
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.0294118	0.3640337510595398
DARWINIAN TUBERCLE OF PINNA	0.0294118	0.3640337510595398
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.0294118	0.3640337510595398
BLAU SYNDROME	0.0294118	0.3640337510595398
EAR WITHOUT HELIX	0.0294118	0.3640337510595398
DARWINIAN POINT OF PINNA	0.0294118	0.3640337510595398
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.0294118	0.3640337510595398
OTOONYCHOPERONEAL SYNDROME	0.0294118	0.3640337510595398
AREDYLD	0.0294118	0.3640337510595398
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.0294118	0.3640337510595398
ALKAPTONURIA	0.0294118	0.3640337510595398
EAR WAX, WET/DRY	0.0294118	0.3640337510595398
MUSICAL PERFECT PITCH	0.0294118	0.3640337510595398
20Q11.2 MICRODUPLICATION SYNDROME	0.02932785	0.3629946907707629
DISTAL MONOSOMY 9P	0.029304010000000002	0.36269961992758915
DISTAL TRISOMY 6P	0.029304010000000002	0.36269961992758915
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.029304010000000002	0.36269961992758915
ENCEPHALITIS LETHARGICA	0.029216370000000002	0.36161488801921027
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.02918584	0.36123701415838405
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.02918584	0.36123701415838405
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.0290068	0.3590210123227364
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.02881156	0.35660450093761675
COFFIN-SIRIS SYNDROME 7; CSS7	0.0287872	0.35630299398544746
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.02864264	0.35451375568472576
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	0.35363200875235573
DYSOSTEOSCLEROSIS	0.0285714	0.35363200875235573
MARFANOID HABITUS WITH SITUS INVERSUS	0.0285714	0.35363200875235573
ACHONDROPLASIA	0.0285714	0.35363200875235573
SCHEIE SYNDROME	0.0285714	0.35363200875235573
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.0285714	0.35363200875235573
CHERUBISM	0.0285714	0.35363200875235573
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	0.35363200875235573
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.02830489	0.35033337912088547
PALLISTER-KILLIAN SYNDROME	0.02829293	0.3501853486139912
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.02825394	0.3497027642106629
CAUDAL REGRESSION SEQUENCE	0.02822181	0.34930508693754314
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.02819178	0.3489334016430587
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.02819178	0.3489334016430587
16P11.2P12.2 MICRODELETION SYNDROME	0.028186239999999998	0.34886483232799226
WOLFRAM-LIKE SYNDROME	0.028130160000000005	0.34817072272710364
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.02810364	0.34784248116833805
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.0278532	0.3447427520590911
LEIGH SYNDROME; LS	0.0278532	0.3447427520590911
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.027777800000000002	0.3438095162547578
301410 NEURAL TUBE DEFECTS, X-LINKEDSPINA BIFIDA, X-LINKED, INCLUDED	0.027777800000000002	0.3438095162547578
MICROHYDRANENCEPHALY; MHAC	0.027777800000000002	0.3438095162547578
SPINA BIFIDA-HYPOSPADIAS SYNDROME	0.027777800000000002	0.3438095162547578
FRONTAL ENCEPHALOCELE	0.027777800000000002	0.3438095162547578
DUPLICATION OF THE PITUITARY GLAND	0.027777800000000002	0.3438095162547578
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.027777800000000002	0.3438095162547578
ISOLATED KLIPPEL-FEIL SYNDROME	0.027777800000000002	0.3438095162547578
ANENCEPHALY; ANPH	0.027777800000000002	0.3438095162547578
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.027777800000000002	0.3438095162547578
ACROPECTOROVERTEBRAL DYSPLASIA	0.027777800000000002	0.3438095162547578
DYSRAPHISM-CLEFT LIP/PALATE-LIMB REDUCTION DEFECTS SYNDROME	0.027777800000000002	0.3438095162547578
NAIL-PATELLA SYNDROME	0.027777800000000002	0.3438095162547578
NEUROFIBROMATOSIS, TYPE I	0.027777800000000002	0.3438095162547578
BASAL CELL NEVUS SYNDROME	0.027777800000000002	0.3438095162547578
ANOPHTHALMIA PLUS SYNDROME	0.027777800000000002	0.3438095162547578
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.02775133	0.3434818935526265
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.027751329999999998	0.3434818935526265
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.027708609999999998	0.34295314244438885
TEMPLE SYNDROME	0.027634159999999998	0.3420316649161048
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.02746664	0.3399582476489708
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.027347820000000002	0.33848759674352147
CLASSIC PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.02727275	0.3375584453929737
PROGRESSIVE SUPRANUCLEAR PALSY	0.02717174	0.3363082312206169
PROGRESSIVE SUPRANUCLEAR PALSY-PARKINSONISM SYNDROME	0.02717174	0.3363082312206169
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.02711961	0.33566301129382786
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.02711961	0.33566301129382786
HEREDITARY CENTRAL DIABETES INSIPIDUS	0.02711961	0.33566301129382786
MUSCULAR HYPERTONIA, LETHAL	0.0270008	0.33419248415970537
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.0270008	0.33419248415970537
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.02697721	0.33390050759970247
FONTAINE PROGEROID SYNDROME; FPS	0.02696699	0.33377401330367745
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0269439	0.3334882253100162
C SYNDROME	0.026921499999999998	0.33321097753790657
AUTOSOMAL DOMINANT HYPOCALCEMIA	0.026914450000000003	0.33312371875248825
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.026894610000000003	0.33287815644004826
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.02682155	0.33197388312619425
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.026795090000000004	0.33164638419538983
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.02678569	0.3315300391481652
SCIMITAR SYNDROME	0.02678569	0.3315300391481652
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.02678569	0.3315300391481652
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.02665516	0.3299144520189925
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.32850147855184814
WOODHOUSE-SAKATI SYNDROME	0.026541000000000002	0.32850147855184814
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.02648988	0.3278687595290694
SHUKLA-VERNON SYNDROME; SHUVER	0.02646159	0.32751861044545416
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.02643455	0.32718393277769325
ALZHEIMER DISEASE 10	0.0263158	0.3257141482715318
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0263158	0.3257141482715318
WILLIAMS-BEUREN SYNDROME (WBS)	0.0263158	0.3257141482715318
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0263158	0.3257141482715318
7Q11.23 DUPLICATION SYNDROME	0.0263158	0.3257141482715318
HYPERLYSINEMIA, TYPE I	0.0263158	0.3257141482715318
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.0263158	0.3257141482715318
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.0263158	0.3257141482715318
ALZHEIMER DISEASE 3; AD	0.0263158	0.3257141482715318
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.02626039	0.325028331349541
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.02619096	0.324168987027328
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.02618362	0.3240781388734314
BAND HETEROTOPIA; BH	0.02611428	0.3232199084931599
COFFIN-SIRIS SYNDROME 8; CSS8	0.026070219999999998	0.32267457202712635
AARSKOG-SCOTT SYNDROME	0.02605704	0.32251144141835836
RICHARDS-RUNDLE SYNDROME; RRNS	0.02601594	0.32200274126506795
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.02599821	0.3217832947025901
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.02594221	0.32109017527231604
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.02587393	0.32024506465268904
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.02586609	0.3201480279324507
OCULOFACIOCARDIODENTAL SYNDROME	0.0258161	0.31952929506960426
FAMILIAL COLD URTICARIA	0.025784539999999998	0.31913867276211405
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.025784539999999998	0.31913867276211405
PRIMARY PARATHYROID HYPERPLASIA	0.025784539999999998	0.31913867276211405
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.025784539999999998	0.31913867276211405
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.025784539999999998	0.31913867276211405
PANHYPOPHYSITIS	0.025784539999999998	0.31913867276211405
PARATHYROID CARCINOMA	0.025784539999999998	0.31913867276211405
FAMILIAL HYPERALDOSTERONISM TYPE III	0.025784539999999998	0.31913867276211405
FAMILIAL HYPERALDOSTERONISM TYPE I	0.025784539999999998	0.31913867276211405
AMYLOIDOSIS	0.025739349999999998	0.3185793501361483
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.025722019999999998	0.31836485442674384
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.025681850000000003	0.3178676650068491
LETTERER-SIWE DISEASE	0.02557931	0.3165985138214865
RETT SYNDROME	0.02557119	0.3164980115040968
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.02557119	0.3164980115040968
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.02553045	0.31599376711857247
MOSAIC TRISOMY 1	0.02538413	0.3141827450643278
TRISOMY 1Q	0.02538413	0.3141827450643278
AGEL AMYLOIDOSIS	0.02527774	0.31286594191813394
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.025015199999999998	0.309616449503417
SCHIZOPHRENIA 4	0.025	0.3094283170866284
SCHIZOPHRENIA 15; SCZD15	0.025	0.3094283170866284
MONILETHRIX	0.025	0.3094283170866284
ACATALASEMIA	0.025	0.3094283170866284
SCHIZOPHRENIA 19; SCZD19	0.025	0.3094283170866284
MADRAS MOTOR NEURON DISEASE	0.025	0.3094283170866284
HYPERPROLINEMIA TYPE 1	0.025	0.3094283170866284
NEPHROPATHIC INFANTILE CYSTINOSIS	0.024953649999999997	0.3088546369867497
CYSTINOSIS, NEPHROPATHIC; CTNS	0.024953649999999997	0.3088546369867497
CYSTINOSIS	0.024953649999999997	0.3088546369867497
TOXIC EPIDERMAL NECROLYSIS	0.024953649999999997	0.3088546369867497
SARCOSINEMIA	0.02479028	0.30683258482025205
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.02468486	0.30552778749276116
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.024595	0.30441557834982497
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.024595	0.30441557834982497
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.024595	0.30441557834982497
FRAGILE X MENTAL RETARDATION SYNDROME	0.02458615	0.3043060407255763
ALG13-CDG	0.02458615	0.3043060407255763
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.02444218	0.30252410493313786
RIFT VALLEY FEVER	0.02441459	0.302182619842401
17Q12 MICRODUPLICATION SYNDROME	0.02441363	0.3021707377950249
SCHWARTZ-JAMPEL SYNDROME	0.02438755	0.3018479421746401
BEEMER LETHAL MALFORMATION SYNDROME	0.02436241	0.3015367810589778
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.02429672	0.300723727213001
LEGIONELLOSIS	0.02429672	0.300723727213001
BENIGN FAMILIAL INFANTILE EPILEPSY	0.02429672	0.300723727213001
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.02428865	0.30062384375224543
AMISH INFANTILE EPILEPSY SYNDROME	0.024255310000000002	0.3002111901485787
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.024255310000000002	0.3002111901485787
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.024255310000000002	0.3002111901485787
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.024255310000000002	0.3002111901485787
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.024255310000000002	0.3002111901485787
LEPTIN RECEPTOR DEFICIENCY; LEPRD	0.02397014	0.296681603221235
FIBROCHONDROGENESIS 1; FBCG1	0.02396516	0.2966199651004713
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.02396516	0.2966199651004713
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.023885479999999997	0.29563375516825274
HYPERTELORISM, TEEBI TYPE; TBHS	0.02387297	0.29547891723838265
BARATELA-SCOTT SYNDROME	0.023845349999999998	0.2951370608336653
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.0238095	0.2946933406269631
DISTAL MONOSOMY 7Q36	0.0238095	0.2946933406269631
CLUSTER HEADACHE, FAMILIAL	0.0238095	0.2946933406269631
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.0238095	0.2946933406269631
CEREBROFACIOTHORACIC DYSPLASIA	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0238095	0.2946933406269631
DISTAL TRISOMY 5Q	0.0238095	0.2946933406269631
H SYNDROME	0.0238095	0.2946933406269631
SIALIDOSIS TYPE 1	0.0238095	0.2946933406269631
FREEMAN-SHELDON SYNDROME	0.0238095	0.2946933406269631
SULFOCYSTEINURIA	0.0238095	0.2946933406269631
HURLER-SCHEIE SYNDROME	0.0238095	0.2946933406269631
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.0238095	0.2946933406269631
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.0238095	0.2946933406269631
ASPARTYLGLUCOSAMINURIA; AGU	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.0238095	0.2946933406269631
PSEUDOMYXOMA PERITONEI	0.0238095	0.2946933406269631
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0238095	0.2946933406269631
BRITTLE CORNEA SYNDROME	0.0238095	0.2946933406269631
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0238095	0.2946933406269631
MUCOPOLYSACCHARIDOSIS TYPE 6	0.0238095	0.2946933406269631
MUCOPOLYSACCHARIDOSIS TYPE 4	0.0238095	0.2946933406269631
GERODERMA OSTEODYSPLASTICA	0.0238095	0.2946933406269631
NON-DISTAL TRISOMY 13Q	0.0238095	0.2946933406269631
TRISOMY 8P	0.0238095	0.2946933406269631
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.0238095	0.2946933406269631
MEHMO SYNDROME	0.0238095	0.2946933406269631
PERIVENTRICULAR NODULAR HETEROTOPIA	0.0238095	0.2946933406269631
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.0238095	0.2946933406269631
6P22 MICRODELETION SYNDROME	0.0238095	0.2946933406269631
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.02380949	0.29469321685563626
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.02377625	0.29428180096523787
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.023692820000000003	0.2932491767854564
KAGAMI-OGATA SYNDROME	0.023650860000000003	0.29272983229805827
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.02354496	0.29141909394687926
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0235043	0.2909158397319695
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0235043	0.2909158397319695
ADAMS-OLIVER SYNDROME 3; AOS3	0.0234672	0.290456648109413
WARSAW BREAKAGE SYNDROME; WABS	0.0234672	0.290456648109413
RABSON-MENDENHALL SYNDROME	0.023384389999999998	0.2894316977518952
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.023375379999999998	0.2893201797864172
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.02325945	0.2878852987944231
EMANUEL SYNDROME	0.02316353	0.28669808422742515
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.02310926	0.2860263772366935
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.023057630000000003	0.28538734587624626
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023008380000000002	0.28477777209158556
RIDDLE SYNDROME	0.02292024	0.2836868516168649
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.02288077	0.2831983261898486
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.02286379	0.2829881624768833
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.2812988076369171
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0227273	0.2812988076369171
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.2812988076369171
BETHLEM MYOPATHY 1	0.0227273	0.2812988076369171
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.2812988076369171
ARTERIES, ANOMALIES OF	0.0227273	0.2812988076369171
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.2812988076369171
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.0227273	0.2812988076369171
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.0227273	0.2812988076369171
WATSON SYNDROME	0.0227273	0.2812988076369171
HYPOADRENOCORTICISM, FAMILIAL	0.0227273	0.2812988076369171
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.2812988076369171
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.2812988076369171
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.2812988076369171
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.2812988076369171
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.2812988076369171
THUMB DEFORMITY	0.0227273	0.2812988076369171
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0227273	0.2812988076369171
COWDEN SYNDROME 6; CWS6	0.0227273	0.2812988076369171
COWDEN SYNDROME 5; CWS5	0.0227273	0.2812988076369171
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.2812988076369171
COCAINE EMBRYOFETOPATHY	0.0227273	0.2812988076369171
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.2812988076369171
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0227273	0.2812988076369171
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.2812988076369171
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.2812988076369171
TAY-SACHS DISEASE; TSD	0.0227273	0.2812988076369171
LARSEN SYNDROME	0.0227273	0.2812988076369171
PREPAPILLARY VASCULAR LOOPS	0.0227273	0.2812988076369171
INFANTILE SIALIC ACID STORAGE DISEASE	0.02268906	0.2808255060831014
RUBINSTEIN-TAYBI SYNDROME	0.02259651	0.27968000245324676
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.022426210000000002	0.27757217675725265
DONNAI-BARROW SYNDROME	0.022304690000000002	0.27606810759355793
MENTAL RETARDATION, X-LINKED 104; MRX104	0.022283240000000003	0.2758026180974977
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.02227729	0.275728974158031
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.022214099999999997	0.2749468631437628
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0220982	0.2735123534657492
ACRODERMATITIS ENTEROPATHICA	0.02208935	0.27340281584150056
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.02199145	0.2721910945517893
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.021988340000000002	0.2721526016691438
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.021988340000000002	0.2721526016691438
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.021988340000000002	0.2721526016691438
DISTAL 16P11.2 MICRODELETION SYNDROME	0.021979810000000002	0.2720470247273538
MELNICK-NEEDLES SYNDROME	0.02191746	0.27127531050453974
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.021852120000000003	0.27046658865500217
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.02174815	0.26917973816990226
PORPHYRIA	0.02173918	0.2690687152897316
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.02157125	0.2669902233981973
INFANT BOTULISM	0.021532080000000002	0.26650541111098597
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.02147715	0.2658255352126832
NEURONAL INTESTINAL PSEUDOOBSTRUCTION	0.021430130000000002	0.2652435624339067
GENITOPALATOCARDIAC SYNDROME	0.021430130000000002	0.2652435624339067
KABUKI SYNDROME	0.021430130000000002	0.2652435624339067
SOTOS SYNDROME	0.021430130000000002	0.2652435624339067
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.02141731	0.2650848875929046
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.02133088	0.26401513201507276
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.0212766	0.2633433012530143
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.0212766	0.2633433012530143
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.0212766	0.2633433012530143
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.0212766	0.2633433012530143
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0212766	0.2633433012530143
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.0212766	0.2633433012530143
HUNTINGTON DISEASE-LIKE 3	0.0212766	0.2633433012530143
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.0212766	0.2633433012530143
POSTORGASMIC ILLNESS SYNDROME	0.02107764	0.26088074693431207
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.02106156	0.26068172264076195
DISTAL MONOSOMY 17Q	0.02106156	0.26068172264076195
BEHÇET DISEASE	0.02106078	0.26067206847726887
PENTALOGY OF CANTRELL	0.02100738	0.2600111295919718
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.02099711	0.25988401643931264
ALLAN-HERNDON-DUDLEY SYNDROME	0.02099711	0.25988401643931264
CONGENITAL HYPOTHYROIDISM	0.02089043	0.25856362392464055
ABLEPHARON MACROSTOMIA SYNDROME	0.0208857	0.25850508008704776
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.02086834	0.2582902130636628
GLAUCOMA - SLEEP APNEA	0.0208333	0.2578565183344342
APNEA, CENTRAL SLEEP	0.0208333	0.2578565183344342
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.0208333	0.2578565183344342
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.0208333	0.2578565183344342
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.0208333	0.2578565183344342
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0208333	0.2578565183344342
GLAUCOMA-SLEEP APNEA SYNDROME	0.0208333	0.2578565183344342
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0208333	0.2578565183344342
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.2578565183344342
AMYOTROPHIC LATERAL SCLEROSIS 1	0.0208333	0.2578565183344342
HYPOCHONDROPLASIA	0.0208333	0.2578565183344342
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.0208333	0.2578565183344342
CLEIDOCRANIAL DYSPLASIA	0.0208333	0.2578565183344342
CROUZON SYNDROME	0.0208333	0.2578565183344342
OSTEOPETROSIS AND RELATED DISORDERS	0.0208333	0.2578565183344342
OROFACIODIGITAL SYNDROME TYPE 14	0.0208333	0.2578565183344342
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.02079591	0.25739373734339943
KLEEFSTRA SYNDROME 2; KLEFS2	0.02079591	0.25739373734339943
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.02079591	0.25739373734339943
19P13.3 MICRODUPLICATION SYNDROME	0.02079591	0.25739373734339943
%614100 CUTIS LAXA, NEONATAL, WITH MARFANOID PHENOTYPE;;CUTIS LAXA-MARFANOID SYNDROME	0.020676729999999997	0.255918630670184
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.020676729999999997	0.255918630670184
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.02057344	0.2546401966353089
FETAL ALCOHOL SYNDROME	0.02052005	0.25397938152133875
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.02051084	0.25386538812932397
HUNTER-MACDONALD SYNDROME	0.02044345	0.2530312931577853
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.020408199999999998	0.2525949992306931
HELIX SYNDROME; HELIX	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 3	0.020408199999999998	0.2525949992306931
OCHOA SYNDROME	0.020408199999999998	0.2525949992306931
NEPHRONOPHTHISIS 4	0.020408199999999998	0.2525949992306931
ERDHEIM-CHESTER DISEASE	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 4; SLSN4	0.020408199999999998	0.2525949992306931
ACQUIRED CENTRAL DIABETES INSIPIDUS	0.020408199999999998	0.2525949992306931
DIABETES INSIPIDUS, NEUROHYPOPHYSEAL TYPE	0.020408199999999998	0.2525949992306931
APPARENT MINERALOCORTICOID EXCESS	0.020408199999999998	0.2525949992306931
NEPHRONOPHTHISIS 1	0.020408199999999998	0.2525949992306931
SENIOR-LOKEN SYNDROME 1	0.020408199999999998	0.2525949992306931
TERATOMA, PINEAL	0.020408199999999998	0.2525949992306931
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.020408199999999998	0.2525949992306931
NEPHROGENIC DIABETES INSIPIDUS	0.020408199999999998	0.2525949992306931
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.020408199999999998	0.2525949992306931
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.02040759	0.25258744917975623
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.02039837	0.2524733320164147
CRANIOFRONTONASAL SYNDROME; CFNS	0.02039837	0.2524733320164147
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.02038343	0.25228841765412374
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.02020041	0.2500231548303959
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.02001114	0.24768053492739647
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.01986931	0.24592508619890063
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.01986931	0.24592508619890063
OHDO SYNDROME	0.01978021	0.2448222836768039
OROFACIODIGITAL SYNDROME TYPE 6	0.0197173	0.2440436382596871
MICROPHTHALMIA, LENZ TYPE	0.01957901	0.24233200458089071
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.019369610000000002	0.2397402329969731
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.01929234	0.2387838519545218
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.01923214	0.23803874856697715
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.0192308	0.2380221632091813
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.0192308	0.2380221632091813
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.0192308	0.2380221632091813
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.0192308	0.2380221632091813
SECONDARY SHORT BOWEL SYNDROME	0.0192308	0.2380221632091813
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.2380221632091813
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.0192308	0.2380221632091813
HYPOTONIA-CYSTINURIA SYNDROME	0.0192308	0.2380221632091813
OBESITY DUE TO CONGENITAL LEPTIN DEFICIENCY	0.0192308	0.2380221632091813
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.01919035	0.2375215081921351
MEHMO SYNDROME; MEHMO	0.01902504	0.2354754443882315
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.01899046	0.23504744314003728
CEREBROTENDINOUS XANTHOMATOSIS	0.01893724	0.2343887321386233
XQ25 MICRODUPLICATION SYNDROME	0.018883900000000002	0.23372853588128728
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	0.23353050175835183
PUBIC BONE DYSPLASIA	0.0188679	0.23353050175835183
RAYNAUD DISEASE	0.0188679	0.23353050175835183
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.23353050175835183
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.23353050175835183
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.23353050175835183
THROMBOCYTOPENIA 3	0.0188679	0.23353050175835183
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.23353050175835183
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.23353050175835183
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.23353050175835183
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.23353050175835183
TRACHEOBRONCHOMEGALY	0.0188679	0.23353050175835183
SPINAL ARACHNOIDITIS	0.0188679	0.23353050175835183
KNUCKLE PADS	0.0188679	0.23353050175835183
MONOPHALANGY OF GREAT TOE	0.0188679	0.23353050175835183
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	0.23353050175835183
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	0.23353050175835183
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.23353050175835183
TOE, MISSHAPEN	0.0188679	0.23353050175835183
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.23353050175835183
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.23353050175835183
VESICOURETERAL REFLUX 1	0.0188679	0.23353050175835183
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.23353050175835183
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.23353050175835183
NEPHROSIALIDOSIS	0.0188679	0.23353050175835183
HHHH SYNDROME	0.0188679	0.23353050175835183
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.0188679	0.23353050175835183
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0188679	0.23353050175835183
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.0188679	0.23353050175835183
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.23353050175835183
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.23353050175835183
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	0.23353050175835183
VAN DEN BOSCH SYNDROME	0.0188679	0.23353050175835183
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.23353050175835183
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.23353050175835183
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.23353050175835183
CARPAL DISPLACEMENT	0.0188679	0.23353050175835183
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.23353050175835183
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.23353050175835183
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.23353050175835183
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.23353050175835183
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.23353050175835183
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.23353050175835183
CHROMOSOME 2Q37 DELETION SYNDROME	0.01882384	0.23298516529231833
CK SYNDROME	0.01869713	0.23141685880999646
9Q21.13 MICRODELETION SYNDROME	0.018616209999999998	0.2304153012332504
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.01857585	0.22991576015814583
RHEUMATIC FEVER	0.01857585	0.22991576015814583
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.01857585	0.22991576015814583
ABETAL34V AMYLOIDOSIS	0.01857585	0.22991576015814583
SNEDDON SYNDROME	0.01857585	0.22991576015814583
FAMILIAL PAROXYSMAL ATAXIA	0.01857585	0.22991576015814583
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.01857585	0.22991576015814583
PFAPA SYNDROME	0.01857585	0.22991576015814583
GORLIN-CHAUDHRY-MOSS SYNDROME	0.018559199999999998	0.2297096808989661
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.01833334	0.22691418171107866
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.01833334	0.22691418171107866
DUBOWITZ SYNDROME	0.01831193	0.2266491873003257
CINCA SYNDROME	0.01820728	0.22535392036500107
HARTSFIELD SYNDROME; HRTFDS	0.0181218	0.2242959230632185
DIAPHRAGMATIC DEFECT-LIMB DEFICIENCY-SKULL DEFECT SYNDROME	0.018031190000000002	0.22317443107076973
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.01771795	0.21929741802900107
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.01771795	0.21929741802900107
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.01771795	0.21929741802900107
CARDIAC VALVULAR DEFECT, DEVELOPMENTAL; CVDD	0.01771795	0.21929741802900107
EVEN-PLUS SYNDROME	0.017682089999999998	0.21885357405097197
OMPHALOCELE	0.01766262	0.21861259127762497
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.01766224	0.21860788796720523
CHROMOSOME 18Q DELETION SYNDROME	0.01761468	0.21801923153677963
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.017614679999999997	0.21801923153677957
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.017611790000000002	0.21798346162332444
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0175439	0.21714317808544398
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0175439	0.21714317808544398
MENTAL RETARDATION, X-LINKED 98; MRX98	0.0175439	0.21714317808544398
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.0175439	0.21714317808544398
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.0175439	0.21714317808544398
ISOLATED COMPLEX I DEFICIENCY	0.0175439	0.21714317808544398
HEART AND BRAIN MALFORMATION SYNDROME	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.0175439	0.21714317808544398
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0175439	0.21714317808544398
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.0175439	0.21714317808544398
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.0175439	0.21714317808544398
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.0175439	0.21714317808544398
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.0175439	0.21714317808544398
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0175439	0.21714317808544398
WILSON-TURNER SYNDROME	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0175439	0.21714317808544398
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.0175439	0.21714317808544398
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0175439	0.21714317808544398
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0175439	0.21714317808544398
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.0175439	0.21714317808544398
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0175439	0.21714317808544398
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0175439	0.21714317808544398
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0175439	0.21714317808544398
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0175439	0.21714317808544398
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.0175439	0.21714317808544398
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0175439	0.21714317808544398
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0175439	0.21714317808544398
1Q41Q42 MICRODELETION SYNDROME	0.01754386	0.21714268300013664
ADRENOLEUKODYSTROPHY	0.017512680000000003	0.2167567640030662
ALPHA-MANNOSIDOSIS	0.01750485	0.21665985105415467
TOWNES-BROCKS SYNDROME 1; TBS1	0.0174314	0.21575075065855412
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.017424540000000002	0.2156658435283456
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.017399309999999998	0.21535356847074172
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.017399309999999998	0.21535356847074172
184705 STEINFELD SYNDROME	0.017399309999999998	0.21535356847074172
FANCONI ANEMIA	0.017399309999999998	0.21535356847074172
COFFIN-SIRIS SYNDROME 2; CSS2	0.017399309999999998	0.21535356847074172
CAMPOMELIC DYSPLASIA	0.017399309999999998	0.21535356847074172
COFFIN-SIRIS SYNDROME 3; CSS3	0.017399309999999998	0.21535356847074172
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.017399309999999998	0.21535356847074172
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.017399309999999998	0.21535356847074172
FRANK-TER HAAR SYNDROME; FTHS	0.017399309999999998	0.21535356847074172
ZTTK SYNDROME; ZTTKS	0.017399309999999998	0.21535356847074172
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.017399309999999998	0.21535356847074172
COFFIN-SIRIS SYNDROME 4; CSS4	0.017399309999999998	0.21535356847074172
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.017399309999999998	0.21535356847074172
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.017399309999999998	0.21535356847074172
212135 CARDIOSKELETAL SYNDROME, KUWAITI TYPE	0.017399309999999998	0.21535356847074172
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.017369279999999997	0.21498188317625724
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.017261890000000002	0.21365270289738
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.21339909544869579
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.21339909544869579
269800 SENILE PLAQUE FORMATION	0.0172414	0.21339909544869579
JUMPING FRENCHMAN OF MAINE	0.0172414	0.21339909544869579
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.21339909544869579
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.21339909544869579
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.21339909544869579
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.21339909544869579
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.21339909544869579
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.21339909544869579
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.21339909544869579
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.21339909544869579
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.21339909544869579
MOTION SICKNESS	0.0172414	0.21339909544869579
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.21339909544869579
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.21339909544869579
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.21339909544869579
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.21339909544869579
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.21339909544869579
PALMOMENTAL REFLEX	0.0172414	0.21339909544869579
TRANSSEXUALITY	0.0172414	0.21339909544869579
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.21339909544869579
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.21339909544869579
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.21339909544869579
DIASTEMATOMYELIA	0.0172414	0.21339909544869579
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.21339909544869579
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.21339909544869579
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.21339909544869579
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.21339909544869579
CERVICAL RIB	0.0172414	0.21339909544869579
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.21339909544869579
MYOPATHY, CONGENITAL	0.0172414	0.21339909544869579
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.21339909544869579
SICKLE CELL ANEMIA	0.0172414	0.21339909544869579
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.21339909544869579
CARDIAC ARRHYTHMIA	0.0172414	0.21339909544869579
MOSAIC TRISOMY 15	0.0172414	0.21339909544869579
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.21339909544869579
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.21339909544869579
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.21339909544869579
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.21339909544869579
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.21339909544869579
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.21339909544869579
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.21339909544869579
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.21339909544869579
PELIZAEUS-MERZBACHER DISEASE	0.017175290000000003	0.21258084320699192
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.017102	0.2116737231526207
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.01707176	0.21129943866027273
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.01707176	0.21129943866027273
19P13.12 MICRODELETION SYNDROME	0.01706069	0.21116242380146677
DISTAL MONOSOMY 6P	0.01706069	0.21116242380146677
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.01704054	0.21091302457789496
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.017020709999999998	0.21066758603678185
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.017020709999999998	0.21066758603678185
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.016974310000000003	0.21009328708026911
MYOCLONIC EPILEPSY OF INFANCY	0.01691523	0.20936204608132994
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.01691523	0.20936204608132994
EISENMENGER SYNDROME	0.01686509	0.208741456648581
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.01681676	0.2081432698259891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.016787540000000004	0.20778161000897832
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0167077	0.2067934197355304
ADIPOSIS DOLOROSA	0.016616930000000002	0.20566994740185232
KENNERKNECHT SYNDROME	0.0166122	0.20561140356425953
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.01654481	0.20477730859272078
BLADDER EXSTROPHY	0.01654481	0.20477730859272078
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.01651533	0.20441243072121226
KAWASAKI DISEASE	0.01651533	0.20441243072121226
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.01651533	0.20441243072121226
CHARGE SYNDROME	0.01650895	0.20433346461469176
HYPERTELORISM, TEEBI TYPE	0.01650895	0.20433346461469176
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.016492640000000003	0.20413159358062444
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.0161783	0.200240965692904
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.01613409	0.19969377265696797
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.01613409	0.19969377265696797
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.01613409	0.19969377265696797
MEIER-GORLIN SYNDROME 7	0.01613409	0.19969377265696797
%608572 BURN-MCKEOWN SYNDROME	0.01613409	0.19969377265696797
COASY PROTEIN-ASSOCIATED NEURODEGENERATION	0.016128999999999998	0.19963077305160914
AUTOIMMUNE HYPOPARATHYROIDISM	0.01608196	0.1990485527301789
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.01608196	0.1990485527301789
MENKES DISEASE	0.01605748	0.19874556052208772
WEAVER SYNDROME	0.01605748	0.19874556052208772
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.01605748	0.19874556052208772
CENTRAL CONGENITAL HYPOTHYROIDISM	0.01596432	0.1975925068412961
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.0157563	0.1950178157004817
YUNIS-VARON SYNDROME	0.0157563	0.1950178157004817
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.01567025	0.1939527634330695
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.01567025	0.1939527634330695
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.01567025	0.1939527634330695
2P15P16.1 MICRODELETION SYNDROME	0.01551878	0.19207799914550505
SPINOCEREBELLAR ATAXIA TYPE 36	0.015268400000000001	0.18897901266421907
CHROMOSOME 9P DELETION SYNDROME	0.0152475	0.18872033059113463
TENORIO SYNDROME; TNORS	0.015235409999999998	0.1885706910569915
3P25.3 MICRODELETION SYNDROME	0.015152080000000002	0.1875393045904784
CONGENITAL ENTEROVIRUS INFECTION	0.01511477	0.1870775137700583
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.01510433	0.18694829650484293
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.01509805	0.18687056811159075
PETERS-PLUS SYNDROME; PTRPLS	0.01506219	0.1864267241335617
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01491044	0.1845484942488459
TRISOMY X	0.014835029999999999	0.18361513467318574
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.014760170000000001	0.18268858252050157
EMANUEL SYNDROME	0.014760170000000001	0.18268858252050157
PSEUDODIASTROPHIC DYSPLASIA	0.01475377	0.1826093688713274
DISTAL TRISOMY 15Q	0.01475377	0.1826093688713274
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.01475377	0.1826093688713274
CUTANEOUS MASTOCYTOSIS	0.014746890000000002	0.18252421419846518
PLAGUE	0.014746890000000002	0.18252421419846518
MALAN OVERGROWTH SYNDROME	0.014730030000000002	0.18231553574142195
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0147059	0.1820168755297699
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.0147059	0.1820168755297699
TRICUSPID ATRESIA	0.0147059	0.1820168755297699
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.0147059	0.1820168755297699
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.0147059	0.1820168755297699
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0147059	0.1820168755297699
RIGHT PULMONARY ARTERY, ANOMALOUS ORIGIN OF, FAMILIAL	0.0147059	0.1820168755297699
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.0147059	0.1820168755297699
VERY LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0147059	0.1820168755297699
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0147059	0.1820168755297699
HARDIKAR SYNDROME	0.0147059	0.1820168755297699
TRANSALDOLASE DEFICIENCY	0.0147059	0.1820168755297699
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0147059	0.1820168755297699
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0147059	0.1820168755297699
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0147059	0.1820168755297699
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0147059	0.1820168755297699
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.0147059	0.1820168755297699
HYPERTELORISM AND TETRALOGY OF FALLOT	0.0147059	0.1820168755297699
CHAR SYNDROME	0.014599319999999999	0.18069772072836618
MUCOPOLYSACCHARIDOSIS TYPE 3	0.01453193	0.1798636257568275
ASPARTYLGLUCOSAMINURIA	0.01453193	0.1798636257568275
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.014523910000000001	0.1797643611527061
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0144928	0.17937930855492348
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.0144928	0.17937930855492348
MAPLE SYRUP URINE DISEASE; MSUD	0.0144928	0.17937930855492348
KETAMINE-INDUCED BILIARY DILATATION	0.0144928	0.17937930855492348
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.014395189999999999	0.17817117663369045
BABESIOSIS	0.01436623	0.17781273487117732
HEMORRHAGIC FEVER-RENAL SYNDROME	0.01434937	0.17760405641413407
AUTISM, SUSCEPTIBILITY TO, 18	0.01428863	0.17685226937494042
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0142857	0.17681600437617787
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0142857	0.17681600437617787
QAZI-MARKOUIZOS SYNDROME	0.0142857	0.17681600437617787
MYOPATHY, DISTAL 3	0.0142857	0.17681600437617787
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.0142857	0.17681600437617787
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.0142857	0.17681600437617787
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0142857	0.17681600437617787
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.0142857	0.17681600437617787
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0142857	0.17681600437617787
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.0142857	0.17681600437617787
HEART-HAND SYNDROME, SLOVENIAN TYPE	0.0142857	0.17681600437617787
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0142857	0.17681600437617787
HYPOPHOSPHATASIA, ADULT	0.0142857	0.17681600437617787
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.0142857	0.17681600437617787
JOUBERT SYNDROME 2	0.0142857	0.17681600437617787
WIEACKER-WOLFF SYNDROME	0.0142857	0.17681600437617787
EXOSTOSES, MULTIPLE, TYPE I	0.0142857	0.17681600437617787
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.0142857	0.17681600437617787
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0142857	0.17681600437617787
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0142857	0.17681600437617787
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.0142857	0.17681600437617787
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.0142857	0.17681600437617787
ORAL SENSIBILITY, DISTURBANCE OF	0.0142857	0.17681600437617787
HAREL-YOON SYNDROME; HAYOS	0.0142857	0.17681600437617787
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.0142857	0.17681600437617787
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0142857	0.17681600437617787
FREE SIALIC ACID STORAGE DISEASE	0.0142857	0.17681600437617787
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.0142857	0.17681600437617787
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0142857	0.17681600437617787
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0142857	0.17681600437617787
INFANTILE-ONSET GENERALIZED DYSKINESIA WITH OROFACIAL INVOLVEMENT	0.0142857	0.17681600437617787
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.0142857	0.17681600437617787
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.0142857	0.17681600437617787
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.0142857	0.17681600437617787
HENNEKAM SYNDROME	0.0142857	0.17681600437617787
HOLMES-GANG SYNDROME	0.0142857	0.17681600437617787
COCKAYNE SYNDROME	0.0142857	0.17681600437617787
CONGENITAL ERYTHROPOIETIC PORPHYRIA	0.0142857	0.17681600437617787
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0142857	0.17681600437617787
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.0142857	0.17681600437617787
FOUNTAIN SYNDROME	0.0142857	0.17681600437617787
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.0142857	0.17681600437617787
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.0142857	0.17681600437617787
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.0142857	0.17681600437617787
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.0142857	0.17681600437617787
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0142857	0.17681600437617787
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.0142857	0.17681600437617787
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.0142857	0.17681600437617787
DEXTROCARDIA	0.0142857	0.17681600437617787
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.0142857	0.17681600437617787
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.0142857	0.17681600437617787
SUPRABULBAR PARESIS, CONGENITAL	0.0142857	0.17681600437617787
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.0142857	0.17681600437617787
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.0142857	0.17681600437617787
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0142857	0.17681600437617787
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0142857	0.17681600437617787
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0142857	0.17681600437617787
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.0142857	0.17681600437617787
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.0142857	0.17681600437617787
COFFIN-SIRIS SYNDROME	0.014266440000000002	0.17657762080069433
CONGENITAL DIAPHRAGMATIC HERNIA	0.014266440000000002	0.17657762080069433
MONOSOMY 9P	0.014266440000000002	0.17657762080069433
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.014266440000000002	0.17657762080069433
MATTHEW-WOOD SYNDROME	0.014266440000000002	0.17657762080069433
KEIPERT SYNDROME	0.014266440000000002	0.17657762080069433
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.014266440000000002	0.17657762080069433
MONOSOMY 18P	0.014266440000000002	0.17657762080069433
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.014248360000000002	0.1763538422417773
CADASIL	0.014248360000000002	0.1763538422417773
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.014248360000000002	0.1763538422417773
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.014248360000000002	0.1763538422417773
LANDAU-KLEFFNER SYNDROME	0.014236410000000001	0.1762059355062099
8P23.1 MICRODELETION SYNDROME	0.014236410000000001	0.1762059355062099
ABETA AMYLOIDOSIS, DUTCH TYPE	0.014148270000000001	0.17511501503148927
CRYPTOCOCCOSIS	0.014148270000000001	0.17511501503148927
PINEOBLASTOMA	0.014148270000000001	0.17511501503148927
INDOLENT SYSTEMIC MASTOCYTOSIS	0.014148270000000001	0.17511501503148927
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.014148270000000001	0.17511501503148927
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.014148270000000001	0.17511501503148927
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0140845	0.1743257252802647
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.0140845	0.1743257252802647
PETTIGREW SYNDROME	0.0140845	0.1743257252802647
HARLEQUIN ICHTHYOSIS	0.0140845	0.1743257252802647
CHROMOSOME 19P13.13 DELETION SYNDROME	0.0140845	0.1743257252802647
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0140845	0.1743257252802647
LESCH-NYHAN SYNDROME; LNS	0.0140845	0.1743257252802647
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.0140845	0.1743257252802647
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.0140845	0.1743257252802647
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.0140845	0.1743257252802647
2Q24 MICRODELETION SYNDROME	0.01406435	0.17407632605669285
5Q14.3 MICRODELETION SYNDROME	0.01406435	0.17407632605669285
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.013957790000000001	0.17275741879794282
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.013957790000000001	0.17275741879794282
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.013957790000000001	0.17275741879794282
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.013957790000000001	0.17275741879794282
ROBERTS SYNDROME	0.01389787	0.17201578100754958
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.01389787	0.17201578100754958
HYDROLETHALUS	0.01389787	0.17201578100754958
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.01389787	0.17201578100754958
GLYCOGEN STORAGE DISEASE XIII; GSD13	0.013888900000000001	0.1719047581273789
PURE MITOCHONDRIAL MYOPATHY	0.013888900000000001	0.1719047581273789
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.013888900000000001	0.1719047581273789
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.013888900000000001	0.1719047581273789
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.013888900000000001	0.1719047581273789
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.013888900000000001	0.1719047581273789
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.013888900000000001	0.1719047581273789
BECKER MUSCULAR DYSTROPHY	0.013888900000000001	0.1719047581273789
EXERCISE INTOLERANCE, RIBOFLAVIN-RESPONSIVE	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.013888900000000001	0.1719047581273789
BARTH SYNDROME; BTHS	0.013888900000000001	0.1719047581273789
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.013888900000000001	0.1719047581273789
GLYCOGEN STORAGE DISEASE XI; GSD11	0.013888900000000001	0.1719047581273789
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 25; LGMDR25	0.013888900000000001	0.1719047581273789
MYOPATHY WITH EXERCISE INTOLERANCE, SWEDISH TYPE	0.013888900000000001	0.1719047581273789
SENGERS SYNDROME	0.013888900000000001	0.1719047581273789
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.013888900000000001	0.1719047581273789
NEMALINE MYOPATHY 6	0.013888900000000001	0.1719047581273789
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.013888900000000001	0.1719047581273789
MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT; IMMD	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 29; MC1DN29	0.013888900000000001	0.1719047581273789
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.013888900000000001	0.1719047581273789
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.013888900000000001	0.1719047581273789
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.013888900000000001	0.1719047581273789
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.013888900000000001	0.1719047581273789
KAPOSIFORM LYMPHANGIOMATOSIS	0.013888900000000001	0.1719047581273789
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.013888900000000001	0.1719047581273789
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.013888900000000001	0.1719047581273789
AUTOSOMAL DOMINANT MITOCHONDRIAL MYOPATHY WITH EXERCISE INTOLERANCE	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL MYOPATHY WITH A DEFECT IN MITOCHONDRIAL-PROTEIN TRANSPORT	0.013888900000000001	0.1719047581273789
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.013888900000000001	0.1719047581273789
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.013888900000000001	0.1719047581273789
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.013888900000000001	0.1719047581273789
HISTIOCYTOID CARDIOMYOPATHY	0.013888900000000001	0.1719047581273789
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.013888900000000001	0.1719047581273789
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.013888900000000001	0.1719047581273789
MUSCLE GLYCOGENOSIS, X-LINKED	0.013888900000000001	0.1719047581273789
PHOSPHOGLYCERATE MUTASE, MUSCLE, DEFICIENCY OF	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.013888900000000001	0.1719047581273789
GLYCOGEN STORAGE DISEASE VII	0.013888900000000001	0.1719047581273789
MYOPATHIC EHLERS-DANLOS SYNDROME	0.013888900000000001	0.1719047581273789
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.013888900000000001	0.1719047581273789
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.013888900000000001	0.1719047581273789
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.013888900000000001	0.1719047581273789
HAMAMY SYNDROME; HMMS	0.01380074	0.17081359011000463
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.01353276	0.16749676609348962
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.01353276	0.16749676609348962
COFFIN-SIRIS SYNDROME 6; CSS6	0.013366780000000002	0.1654424096106881
2Q31.1 MICRODELETION SYNDROME	0.013341180000000001	0.1651255550139914
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.01331738	0.16483097925612492
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.013307010000000001	0.16470262839019736
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.013285489999999999	0.1644362724948492
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.013285489999999999	0.1644362724948492
GENITOPATELLAR SYNDROME; GTPTS	0.013285489999999999	0.1644362724948492
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.0131579	0.1628570741357659
SCALP-EAR-NIPPLE SYNDROME; SENS	0.0131579	0.1628570741357659
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0131579	0.1628570741357659
BRACHYDACTYLY, TYPE A2; BDA2	0.0131579	0.1628570741357659
MEND SYNDROME; MEND	0.0131579	0.1628570741357659
FEINGOLD SYNDROME 1; FGLDS1	0.0131579	0.1628570741357659
SYNDACTYLY TYPE 5	0.0131579	0.1628570741357659
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.0131579	0.1628570741357659
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.0131579	0.1628570741357659
CHROMOSOME 2Q35 DUPLICATION SYNDROME	0.0131579	0.1628570741357659
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0131579	0.1628570741357659
BRACHYDACTYLY TYPE A7	0.0131579	0.1628570741357659
X SMALL RINGS	0.0131579	0.1628570741357659
SYNDACTYLY, TYPE IV; SDTY4	0.0131579	0.1628570741357659
JACKSON-WEISS SYNDROME	0.0131579	0.1628570741357659
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.0131579	0.1628570741357659
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.0131579	0.1628570741357659
MESOAXIAL SYNOSTOTIC SYNDACTYLY WITH PHALANGEAL REDUCTION	0.0131579	0.1628570741357659
SYNDACTYLY TYPE 2	0.0131579	0.1628570741357659
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.0131579	0.1628570741357659
COOPER-JABS SYNDROME	0.01304543	0.16146501802285657
15Q14 MICRODELETION SYNDROME	0.01303049	0.1612801036605656
CORNEODERMATOOSSEOUS SYNDROME	0.012948810000000002	0.1602691394629802
CORNEODERMATOOSSEOUS SYNDROME	0.012948810000000002	0.1602691394629802
APERT SYNDROME	0.01284745	0.15901459329418413
BARTSOCAS-PAPAS SYNDROME	0.01284745	0.15901459329418413
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.01281742	0.15864290799969968
X-LINKED EHLERS-DANLOS SYNDROME	0.012780060000000001	0.1581804983226454
ACHONDROGENESIS	0.01278006	0.1581804983226454
ACROOSTEOLYSIS DOMINANT TYPE	0.01266189	0.15671789255344035
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.012658200000000001	0.1566722209338384
AUTOSOMAL RECESSIVE AMELIA	0.012658200000000001	0.1566722209338384
PHACE SYNDROME	0.012658200000000001	0.1566722209338384
GERMAN SYNDROME	0.012658200000000001	0.1566722209338384
JOHANSON-BLIZZARD SYNDROME	0.012658200000000001	0.1566722209338384
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.012658200000000001	0.1566722209338384
CONGENITAL AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.012658200000000001	0.1566722209338384
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.012658200000000001	0.1566722209338384
%601612 LUNG AGENESIS, CONGENITAL HEART DEFECTS, AND THUMB ANOMALIES SYNDROME;LACHT;;MARDINI-NYHAN ASSOCIATION	0.012658200000000001	0.1566722209338384
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.012658200000000001	0.1566722209338384
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.012658200000000001	0.1566722209338384
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.012658200000000001	0.1566722209338384
CONGENITAL LARYNGEAL WEB	0.012658200000000001	0.1566722209338384
1Q44 MICRODELETION SYNDROME	0.012658200000000001	0.1566722209338384
PENTASOMY X	0.012658200000000001	0.1566722209338384
BALLER-GEROLD SYNDROME	0.012658200000000001	0.1566722209338384
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.012658200000000001	0.1566722209338384
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.012658200000000001	0.1566722209338384
NOONAN SYNDROME 2; NS2	0.012658200000000001	0.1566722209338384
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.012658200000000001	0.1566722209338384
ATRIAL SEPTAL DEFECT-ATRIOVENTRICULAR CONDUCTION DEFECTS SYNDROME	0.012658200000000001	0.1566722209338384
LARYNGOTRACHEOESOPHAGEAL CLEFT TYPE 4	0.012658200000000001	0.1566722209338384
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.012658200000000001	0.1566722209338384
CHOPS SYNDROME; CHOPS	0.012658200000000001	0.1566722209338384
DISTAL MONOSOMY 13Q	0.012658200000000001	0.1566722209338384
NOONAN SYNDROME 9; NS9	0.012658200000000001	0.1566722209338384
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.012658200000000001	0.1566722209338384
NOONAN SYNDROME 10; NS10	0.012658200000000001	0.1566722209338384
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.012658200000000001	0.1566722209338384
DIPROSOPUS	0.012658200000000001	0.1566722209338384
CONGENITAL PERICARDIUM ANOMALY	0.012658200000000001	0.1566722209338384
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.012658200000000001	0.1566722209338384
TRACHEAL AGENESIS	0.012658200000000001	0.1566722209338384
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.01262272	0.156233080266229
PREECLAMPSIA	0.01262272	0.156233080266229
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.1547974566462739
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.01250673	0.1547974566462739
TUBEROUS SCLEROSIS 2; TSC2	0.01250673	0.1547974566462739
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.01250673	0.1547974566462739
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.01250673	0.1547974566462739
TUBEROUS SCLEROSIS-1	0.01250673	0.1547974566462739
10Q22.3Q23.3 MICRODELETION SYNDROME	0.01250673	0.1547974566462739
RECESSIVE X-LINKED ICHTHYOSIS	0.01250673	0.1547974566462739
OMPHALOCELE, AUTOSOMAL	0.01227131	0.15188363206993252
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.01223545	0.15143978809190348
3MC SYNDROME 1	0.01223545	0.15143978809190348
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01223545	0.15143978809190348
CODAS SYNDROME	0.01223545	0.15143978809190348
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.01223545	0.15143978809190348
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.01220592	0.15107429136376074
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.01217589	0.1507026060692763
STURGE-WEBER SYNDROME	0.01217589	0.1507026060692763
XQ25 DUPLICATION SYNDROME	0.012172490000000001	0.15066052381815254
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.012087750000000001	0.14961168559455568
RHABDOID TUMOR	0.012087750000000001	0.14961168559455568
NARP SYNDROME	0.012087750000000001	0.14961168559455568
WYBURN-MASON SYNDROME	0.012087750000000001	0.14961168559455568
MEDULLOBLASTOMA	0.012087750000000001	0.14961168559455568
AICARDI-GOUTIÈRES SYNDROME	0.012087750000000001	0.14961168559455568
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.012086	0.1495900256123596
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.012086	0.1495900256123596
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.012048200000000002	0.14912216999692465
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.012048200000000002	0.14912216999692465
WERNICKE-KORSAKOFF SYNDROME	0.012048200000000002	0.14912216999692465
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.012048200000000002	0.14912216999692465
PORPHYRIA VARIEGATA	0.012048200000000002	0.14912216999692465
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.012048200000000002	0.14912216999692465
MIXED CONNECTIVE TISSUE DISEASE	0.012048200000000002	0.14912216999692465
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.012048200000000002	0.14912216999692465
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.012048200000000002	0.14912216999692465
SHEEHAN SYNDROME	0.012048200000000002	0.14912216999692465
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.012048200000000002	0.14912216999692465
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.012048200000000002	0.14912216999692465
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.012048200000000002	0.14912216999692465
DEMENTIA, FAMILIAL DANISH	0.012048200000000002	0.14912216999692465
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.01198572	0.14834884674686172
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.01198572	0.14834884674686172
TRANSIENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.14734728917011572
DISTAL TRISOMY 17Q	0.011904799999999998	0.14734728917011572
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.011904799999999998	0.14734728917011572
CONGENITAL HYDROCEPHALUS	0.011904799999999998	0.14734728917011572
7P22.1 MICRODUPLICATION SYNDROME	0.011904799999999998	0.14734728917011572
AA AMYLOIDOSIS	0.011904799999999998	0.14734728917011572
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.011904799999999998	0.14734728917011572
PERMANENT NEONATAL DIABETES MELLITUS	0.011904799999999998	0.14734728917011572
UNILATERAL POLYMICROGYRIA	0.011904799999999998	0.14734728917011572
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.011904799999999998	0.14734728917011572
NF1-MICRODELETION SYNDROME	0.011904799999999998	0.14734728917011572
WOLCOTT-RALLISON SYNDROME	0.011904799999999998	0.14734728917011572
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.011904799999999998	0.14734728917011572
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.011904799999999998	0.14734728917011572
9Q SUBTELOMERIC DELETION SYNDROME	0.011904799999999998	0.14734728917011572
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.011904799999999998	0.14734728917011572
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.011904799999999998	0.14734728917011572
CAT-EYE SYNDROME (TYPE I)	0.011904799999999998	0.14734728917011572
AFRICAN IRON OVERLOAD	0.011904799999999998	0.14734728917011572
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.011904799999999998	0.14734728917011572
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.011904799999999998	0.14734728917011572
MILLER-DIEKER SYNDROME (MDS)	0.011904799999999998	0.14734728917011572
LOWRY-MACLEAN SYNDROME	0.011904799999999998	0.14734728917011572
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.011904799999999998	0.14734728917011572
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.011904799999999998	0.14734728917011572
CRANIOFACIOFRONTODIGITAL SYNDROME	0.011904799999999998	0.14734728917011572
TIBIA, HYPOPLASIA OR APLASIA OF, WITH POLYDACTYLY	0.011904799999999998	0.14734728917011572
22Q11 DELETION SYNDROME (VELOCARDIOFACIAL / DIGEORGE SYNDROME)	0.011904799999999998	0.14734728917011572
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.01189839	0.1472679517496147
ERMINE PHENOTYPE	0.01189839	0.1472679517496147
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.011831	0.146433856778076
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.01179738	0.14601773757725792
2Q33.1 DELETION SYNDROME	0.011783980000000001	0.1458518839992995
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.011783980000000001	0.1458518839992995
AYMÉ-GRIPP SYNDROME	0.011783980000000001	0.1458518839992995
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 1	0.011783980000000001	0.1458518839992995
LOWRY-MACLEAN SYNDROME	0.011783980000000001	0.1458518839992995
ANGELMAN SYNDROME	0.011783980000000001	0.1458518839992995
ACROCALLOSAL SYNDROME	0.011783980000000001	0.1458518839992995
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.01178159	0.145822302652186
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.01178159	0.145822302652186
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.01174812	0.14540804002127042
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.01174812	0.14540804002127042
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.01174812	0.14540804002127042
17Q23.1Q23.2 MICRODELETION SYNDROME	0.01174812	0.14540804002127042
SECKEL SYNDROME 9; SCKL9	0.01174812	0.14540804002127042
8P23.1 DELETION SYNDROME	0.01174812	0.14540804002127042
WOLF-HIRSCHHORN SYNDROME	0.01174812	0.14540804002127042
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.01163752	0.14403912914647915
OCULODENTODIGITAL DYSPLASIA	0.011626439999999998	0.14390199051634633
CARPENTER SYNDROME	0.011626439999999998	0.14390199051634633
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.011626439999999998	0.14390199051634633
PRIMARY CONGENITAL HYPOTHYROIDISM	0.01151988	0.1425830832575963
PERIPHERAL HYPOTHYROIDISM	0.01151988	0.1425830832575963
PERMANENT CONGENITAL HYPOTHYROIDISM	0.01151988	0.1425830832575963
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01151988	0.1425830832575963
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.01151988	0.1425830832575963
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.01151988	0.1425830832575963
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.01151988	0.1425830832575963
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.01151988	0.1425830832575963
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.01151988	0.1425830832575963
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.011450749999999999	0.14172745207518836
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.011450749999999999	0.14172745207518836
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.011450749999999999	0.14172745207518836
FRIED SYNDROME	0.011450749999999999	0.14172745207518836
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01141541	0.14129004420615474
DIAMOND-BLACKFAN ANEMIA 1	0.01137955	0.14084620022812566
KNIEST-LIKE DYSPLASIA, LETHAL	0.01137955	0.14084620022812566
EBSTEIN MALFORMATION	0.01137955	0.14084620022812566
CARDIOFACIOCUTANEOUS SYNDROME	0.01137955	0.14084620022812566
RESTRICTIVE DERMOPATHY, LETHAL	0.01137955	0.14084620022812566
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01137955	0.14084620022812566
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.01137955	0.14084620022812566
INDOMETHACIN EMBRYOFETOPATHY	0.01137955	0.14084620022812566
JUVENILE HUNTINGTON DISEASE	0.01115585	0.13807743564683453
15Q OVERGROWTH SYNDROME	0.010870850000000001	0.13454995283204696
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.01082455	0.13397689158880252
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.01082455	0.13397689158880252
BOHRING-OPITZ SYNDROME	0.01078869	0.13353304761077348
RITSCHER-SCHINZEL SYNDROME 1	0.01078869	0.13353304761077348
DUANE-RADIAL RAY SYNDROME; DRRS	0.01078869	0.13353304761077348
YUNIS-VARON SYNDROME	0.01078869	0.13353304761077348
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.01078869	0.13353304761077348
ROBERTS SYNDROME; RBS	0.01078869	0.13353304761077348
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.01078869	0.13353304761077348
FACIOCARDIORENAL SYNDROME	0.01036499	0.12828885649278926
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01036499	0.12828885649278926
ADAMS-OLIVER SYNDROME 1; AOS1	0.010329129999999999	0.12784501251476021
ABRUZZO-ERICKSON SYNDROME	0.010329129999999999	0.12784501251476021
ACROCARDIOFACIAL SYNDROME	0.010329129999999999	0.12784501251476021
TOWNES-BROCKS SYNDROME	0.010329129999999999	0.12784501251476021
CORNELIA DE LANGE SYNDROME 3	0.010329129999999999	0.12784501251476021
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.010329129999999999	0.12784501251476021
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.010309299999999999	0.1275995739736471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010309299999999999	0.1275995739736471
GLYCEROL KINASE DEFICIENCY; GKD	0.010309299999999999	0.1275995739736471
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.010309299999999999	0.1275995739736471
GABA-TRANSAMINASE DEFICIENCY	0.010309299999999999	0.1275995739736471
MEVALONIC ACIDURIA; MEVA	0.010309299999999999	0.1275995739736471
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.010309299999999999	0.1275995739736471
HYDROCEPHALUS, NORMAL-PRESSURE	0.010309299999999999	0.1275995739736471
PROPIONIC ACIDEMIA	0.010309299999999999	0.1275995739736471
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.010309299999999999	0.1275995739736471
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.010309299999999999	0.1275995739736471
CREE MENTAL RETARDATION SYNDROME	0.010309299999999999	0.1275995739736471
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.010309299999999999	0.1275995739736471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.010309299999999999	0.1275995739736471
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.010309299999999999	0.1275995739736471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.010309299999999999	0.1275995739736471
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.010309299999999999	0.1275995739736471
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.010309299999999999	0.1275995739736471
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010309299999999999	0.1275995739736471
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.010309299999999999	0.1275995739736471
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.010309299999999999	0.1275995739736471
GAUCHER DISEASE, TYPE II	0.010309299999999999	0.1275995739736471
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.010309299999999999	0.1275995739736471
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.010309299999999999	0.1275995739736471
MUSCULAR DYSTROPHY, CONGENITAL, WITH SEVERE CENTRAL NERVOUS SYSTEM ATROPHY AND ABSENCE OF LARGE MYELINATED FIBERS	0.010309299999999999	0.1275995739736471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.010309299999999999	0.1275995739736471
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.010309299999999999	0.1275995739736471
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.010309299999999999	0.1275995739736471
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.010309299999999999	0.1275995739736471
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.010309299999999999	0.1275995739736471
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.010309299999999999	0.1275995739736471
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.010309299999999999	0.1275995739736471
PIERSON SYNDROME	0.010309299999999999	0.1275995739736471
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.010309299999999999	0.1275995739736471
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.010309299999999999	0.1275995739736471
VICI SYNDROME; VICIS	0.010309299999999999	0.1275995739736471
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.010309299999999999	0.1275995739736471
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.010309299999999999	0.1275995739736471
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.010309299999999999	0.1275995739736471
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.010309299999999999	0.1275995739736471
ONYCHOTRICHODYSPLASIA AND NEUTROPENIA	0.010309299999999999	0.1275995739736471
LISSENCEPHALY 5; LIS5	0.010309299999999999	0.1275995739736471
ADAMS-OLIVER SYNDROME 2; AOS2	0.010309299999999999	0.1275995739736471
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.010309299999999999	0.1275995739736471
MARINESCO-SJOGREN SYNDROME; MSS	0.010309299999999999	0.1275995739736471
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.010309299999999999	0.1275995739736471
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.010309299999999999	0.1275995739736471
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.010309299999999999	0.1275995739736471
SEPTOOPTIC DYSPLASIA	0.010309299999999999	0.1275995739736471
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.010309299999999999	0.1275995739736471
PYRUVATE CARBOXYLASE DEFICIENCY	0.010309299999999999	0.1275995739736471
REVESZ SYNDROME	0.010309299999999999	0.1275995739736471
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.010309299999999999	0.1275995739736471
ARIMA SYNDROME	0.010309299999999999	0.1275995739736471
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.010309299999999999	0.1275995739736471
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.010309299999999999	0.1275995739736471
NIEMANN-PICK DISEASE, TYPE A	0.010309299999999999	0.1275995739736471
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.010309299999999999	0.1275995739736471
CHROMOSOME 4Q21 DELETION SYNDROME	0.010309299999999999	0.1275995739736471
MENTAL RETARDATION, X-LINKED 91; MRX91	0.010309299999999999	0.1275995739736471
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.010309299999999999	0.1275995739736471
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.010309299999999999	0.1275995739736471
ACQUIRED METHEMOGLOBINEMIA	0.010302450000000001	0.12751479061476537
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.01026174	0.12701091754322152
FLOATING-HARBOR SYNDROME	0.01026174	0.12701091754322152
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.010203819999999999	0.1262940340181952
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.010203819999999999	0.1262940340181952
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.01001844	0.12399956116133444
SCRUB TYPHUS	0.00992179	0.12280331128747754
ALPORT SYNDROME	0.00992179	0.12280331128747754
YELLOW FEVER	0.00992179	0.12280331128747754
IDIOPATHIC PANUVEITIS	0.00992179	0.12280331128747754
SPINOCEREBELLAR ATAXIA 14	0.00990892	0.12264401758984134
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.009820780000000001	0.12155309711512072
GIANT CELL ARTERITIS	0.009820780000000001	0.12155309711512072
L1 SYNDROME	0.009820780000000001	0.12155309711512072
CENTRAL NEUROCYTOMA	0.009820780000000001	0.12155309711512072
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00980392	0.1213444186580775
PHACE ASSOCIATION	0.00980392	0.1213444186580775
PAROXYSMAL KINESIGENIC DYSKINESIA	0.00980392	0.1213444186580775
NEUROFIBROMATOSIS TYPE 2	0.00980392	0.1213444186580775
VON HIPPEL-LINDAU DISEASE	0.00980392	0.1213444186580775
PULMONARY ARTERIOVENOUS MALFORMATION	0.00980392	0.1213444186580775
CLASSIC HODGKIN LYMPHOMA	0.00980392	0.1213444186580775
MALIGNANT ATROPHIC PAPULOSIS	0.00980392	0.1213444186580775
SUBEPENDYMOMA	0.00980392	0.1213444186580775
CITRULLINEMIA TYPE I	0.00980392	0.1213444186580775
STORMORKEN SYNDROME; STRMK	0.00980392	0.1213444186580775
EPENDYMOMA	0.00980392	0.1213444186580775
PEROXISOME BIOGENESIS DISORDER 14B	0.00980392	0.1213444186580775
PERIODIC FEVER, MENSTRUAL CYCLE-DEPENDENT	0.00980392	0.1213444186580775
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.00980392	0.1213444186580775
IMMUNOGLOBULIN A VASCULITIS	0.00980392	0.1213444186580775
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.00980392	0.1213444186580775
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00980392	0.1213444186580775
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.00980392	0.1213444186580775
ARACHNOIDITIS	0.00980392	0.1213444186580775
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.00980392	0.1213444186580775
VIRAL HEMORRHAGIC FEVER	0.00980392	0.1213444186580775
EPISODIC ATAXIA, TYPE 2	0.00980392	0.1213444186580775
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00980392	0.1213444186580775
SYSTEMIC SCLEROSIS	0.00980392	0.1213444186580775
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	0.1213444186580775
KERION CELSI	0.00980392	0.1213444186580775
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.00980392	0.1213444186580775
TAKAYASU ARTERITIS	0.00980392	0.1213444186580775
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00980392	0.1213444186580775
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.00980392	0.1213444186580775
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.00980392	0.1213444186580775
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00980392	0.1213444186580775
BERNARD-SOULIER SYNDROME	0.00980392	0.1213444186580775
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00980392	0.1213444186580775
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 4; HHT4	0.00980392	0.1213444186580775
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.00980392	0.1213444186580775
EPISODIC ATAXIA TYPE 7	0.00980392	0.1213444186580775
BLACKFAN-DIAMOND ANEMIA	0.00980392	0.1213444186580775
FAMILIAL VISCERAL MYOPATHY	0.00976801	0.12089995582341428
DOWN SYNDROME	0.00976801	0.12089995582341428
MESOMELIA-SYNOSTOSES SYNDROME	0.00976801	0.12089995582341428
INCONTINENTIA PIGMENTI	0.00973798	0.12052827052892981
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.009687600000000001	0.11990471058433685
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.009687600000000001	0.11990471058433685
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.009687600000000001	0.11990471058433685
20Q13.33 MICRODELETION SYNDROME	0.009687600000000001	0.11990471058433685
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.009687600000000001	0.11990471058433685
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.009687600000000001	0.11990471058433685
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.009665449999999999	0.11963055709539806
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.00937055	0.11598054066704422
ACTH-INDEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704422
ACTH-DEPENDENT CUSHING SYNDROME	0.00937055	0.11598054066704422
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.00937055	0.11598054066704422
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00937055	0.11598054066704422
PARKINSON DISEASE 6, AUTOSOMAL RECESSIVE EARLY-ONSET	0.00937055	0.11598054066704422
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00937055	0.11598054066704422
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00937055	0.11598054066704422
BETA-THALASSEMIA MAJOR	0.00937055	0.11598054066704422
AUTOIMMUNE HEPATITIS	0.00937055	0.11598054066704422
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.00937055	0.11598054066704422
DYSTONIA 26, MYOCLONIC; DYT26	0.00937055	0.11598054066704422
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.00937055	0.11598054066704422
FABRY DISEASE	0.00937055	0.11598054066704422
BECKWITH-WIEDEMANN SYNDROME	0.00925926	0.11460308957070137
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00925926	0.11460308957070137
ISOLATED TRIGONOCEPHALY	0.00925926	0.11460308957070137
TIBIAL APLASIA-ECTRODACTYLY SYNDROME	0.00925926	0.11460308957070137
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00925926	0.11460308957070137
ACROCEPHALOSYNDACTYLY	0.00925926	0.11460308957070137
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00925926	0.11460308957070137
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00925926	0.11460308957070137
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00925926	0.11460308957070137
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00925926	0.11460308957070137
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.00925926	0.11460308957070137
HOLOPROSENCEPHALY 7	0.00925926	0.11460308957070137
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00925926	0.11460308957070137
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00925926	0.11460308957070137
SHPRINTZEN OMPHALOCELE SYNDROME	0.00925926	0.11460308957070137
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.00925926	0.11460308957070137
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.00925926	0.11460308957070137
MANITOBA OCULOTRICHOANAL SYNDROME	0.00925926	0.11460308957070137
MELNICK-NEEDLES SYNDROME	0.00925926	0.11460308957070137
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00925926	0.11460308957070137
FETAL VALPROATE SYNDROME	0.00925926	0.11460308957070137
HYDROLETHALUS SYNDROME 1	0.00925926	0.11460308957070137
BOOMERANG DYSPLASIA	0.00925926	0.11460308957070137
OMPHALOCELE	0.00925926	0.11460308957070137
CERVICAL RIBS, SPRENGEL ANOMALY, ANAL ATRESIA, AND URETHRAL OBSTRUCTION	0.00925926	0.11460308957070137
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00925926	0.11460308957070137
FIBROCHONDROGENESIS	0.00925926	0.11460308957070137
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00925926	0.11460308957070137
COLONIC ATRESIA	0.00925926	0.11460308957070137
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.009183779999999999	0.11366886359575341
SPINOCEREBELLAR ATAXIA TYPE 27	0.009183779999999999	0.11366886359575341
GAPO SYNDROME; GAPOS	0.008818949999999999	0.10915331427884484
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.008818949999999999	0.10915331427884484
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 38	0.00877193	0.10857134150006832
LESCH-NYHAN SYNDROME	0.00877193	0.10857134150006832
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.00877193	0.10857134150006832
CRANIOFRONTONASAL DYSPLASIA	0.00877193	0.10857134150006832
DIAMOND-BLACKFAN ANEMIA 10	0.00877193	0.10857134150006832
MENTAL RETARDATION, X-LINKED 105; MRX105	0.00877193	0.10857134150006832
HISTIDINEMIA	0.00877193	0.10857134150006832
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.10857134150006832
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.00877193	0.10857134150006832
9Q33.3Q34.11 MICRODELETION SYNDROME	0.00877193	0.10857134150006832
DEAFNESS-HYPOGONADISM SYNDROME	0.00877193	0.10857134150006832
5Q35 MICRODUPLICATION SYNDROME	0.00877193	0.10857134150006832
SCLERODERMA	0.00877193	0.10857134150006832
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.00877193	0.10857134150006832
HERNIA, ANTERIOR DIAPHRAGMATIC	0.00877193	0.10857134150006832
ISOLATED CEREBELLAR AGENESIS	0.00877193	0.10857134150006832
ACRO-RENAL-MANDIBULAR SYNDROME	0.00877193	0.10857134150006832
METACHROMATIC LEUKODYSTROPHY	0.00877193	0.10857134150006832
SERKAL SYNDROME	0.00877193	0.10857134150006832
HEREDITARY FOLATE MALABSORPTION	0.00877193	0.10857134150006832
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.00877193	0.10857134150006832
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00877193	0.10857134150006832
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.00877193	0.10857134150006832
MILROY DISEASE	0.00877193	0.10857134150006832
MENTAL RETARDATION, X-LINKED 90	0.00877193	0.10857134150006832
DELAYED ENCEPHALOPATHY DUE TO CARBON MONOXIDE POISONING	0.00877193	0.10857134150006832
MICROPHTHALMIA, SYNDROMIC 12	0.00877193	0.10857134150006832
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00877193	0.10857134150006832
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.00877193	0.10857134150006832
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.00877193	0.10857134150006832
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.00877193	0.10857134150006832
THAKKER-DONNAI SYNDROME	0.00877193	0.10857134150006832
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00877193	0.10857134150006832
ADULT POLYGLUCOSAN BODY DISEASE	0.00877193	0.10857134150006832
FAMILIAL DYSAUTONOMIA	0.00877193	0.10857134150006832
CUTIS LAXA-MARFANOID SYNDROME	0.00877193	0.10857134150006832
INFANTILE REFSUM DISEASE	0.00877193	0.10857134150006832
NANCE-HORAN SYNDROME	0.00877193	0.10857134150006832
DIENCEPHALIC SYNDROME	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, IOWA TYPE	0.00877193	0.10857134150006832
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.00877193	0.10857134150006832
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00877193	0.10857134150006832
HISTIDINEMIA	0.00877193	0.10857134150006832
NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006832
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00877193	0.10857134150006832
OCULOCEREBROCUTANEOUS SYNDROME	0.00877193	0.10857134150006832
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00877193	0.10857134150006832
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.00877193	0.10857134150006832
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.00877193	0.10857134150006832
L-2-HYDROXYGLUTARIC ACIDURIA	0.00877193	0.10857134150006832
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00877193	0.10857134150006832
NEUROFERRITINOPATHY	0.00877193	0.10857134150006832
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.00877193	0.10857134150006832
DIAPHRAGMATIC HERNIA, CONGENITAL	0.00877193	0.10857134150006832
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00877193	0.10857134150006832
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.00877193	0.10857134150006832
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00877193	0.10857134150006832
DIAPHRAGMATIC HERNIA 2	0.00877193	0.10857134150006832
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.00877193	0.10857134150006832
HSD10 DISEASE, ATYPICAL TYPE	0.00877193	0.10857134150006832
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00877193	0.10857134150006832
EPIDERMOLYSIS BULLOSA WITH DIAPHRAGMATIC HERNIA	0.00877193	0.10857134150006832
HUNTINGTON DISEASE	0.00877193	0.10857134150006832
MONOAMINE OXIDASE A DEFICIENCY	0.00877193	0.10857134150006832
HUMEROFEMORAL HYPOPLASIA WITH RADIOTIBIAL RAY DEFICIENCY; HHRRD	0.00877193	0.10857134150006832
LOCKED-IN SYNDROME	0.00877193	0.10857134150006832
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 21	0.00877193	0.10857134150006832
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.00877193	0.10857134150006832
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 12	0.00877193	0.10857134150006832
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Y	0.00877193	0.10857134150006832
BREATH-HOLDING SPELLS	0.00877193	0.10857134150006832
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00877193	0.10857134150006832
CORTICOBASAL SYNDROME	0.00877193	0.10857134150006832
ARGININEMIA	0.00877193	0.10857134150006832
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00877193	0.10857134150006832
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.00877193	0.10857134150006832
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.00877193	0.10857134150006832
SPINOCEREBELLAR ATAXIA TYPE 17	0.00877193	0.10857134150006832
CAFFEY DISEASE	0.00877193	0.10857134150006832
20Q11.2 MICRODELETION SYNDROME	0.00877193	0.10857134150006832
MONOSOMY 5P	0.00850656	0.10528682179985717
FEMORAL-FACIAL SYNDROME	0.00850656	0.10528682179985717
WEAVER SYNDROME	0.00850656	0.10528682179985717
BOHRING-OPITZ SYNDROME	0.00850656	0.10528682179985717
8Q12 MICRODUPLICATION SYNDROME	0.00844067	0.10447129252734366
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.00844067	0.10447129252734366
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.00840336	0.10400950170692358
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.10400950170692358
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.10400950170692358
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.00840336	0.10400950170692358
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.10400950170692358
GMS SYNDROME	0.00840336	0.10400950170692358
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.10400950170692358
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00840336	0.10400950170692358
PEMPHIGOID GESTATIONIS	0.00840336	0.10400950170692358
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.10400950170692358
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.10400950170692358
ROIFMAN SYNDROME; RFMN	0.00840336	0.10400950170692358
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.10400950170692358
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.00840336	0.10400950170692358
ZELLWEGER SYNDROME	0.00840336	0.10400950170692358
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.10400950170692358
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.10400950170692358
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.00840336	0.10400950170692358
HEC SYNDROME	0.00840336	0.10400950170692358
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.10400950170692358
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.10400950170692358
CONGENITAL TOXOPLASMOSIS	0.00840336	0.10400950170692358
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.00840336	0.10400950170692358
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	0.10400950170692358
NEMALINE MYOPATHY 10	0.00840336	0.10400950170692358
CONGENITAL ANALBUMINEMIA	0.00840336	0.10400950170692358
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.10400950170692358
ADAMS-OLIVER SYNDROME	0.00840336	0.10400950170692358
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.10400950170692358
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.00840336	0.10400950170692358
RENAL TUBULAR DYSGENESIS	0.00840336	0.10400950170692358
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.10400950170692358
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.10400950170692358
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.10400950170692358
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00840336	0.10400950170692358
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.00840336	0.10400950170692358
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.10400950170692358
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.10400950170692358
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.10400950170692358
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.10400950170692358
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.00840336	0.10400950170692358
RETINOPATHY OF PREMATURITY	0.00840336	0.10400950170692358
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.10400950170692358
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.10400950170692358
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.10400950170692358
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.10400950170692358
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.10400950170692358
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.10400950170692358
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.10400950170692358
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.10400950170692358
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.00840336	0.10400950170692358
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.00840336	0.10400950170692358
TEMPLE SYNDROME	0.00840336	0.10400950170692358
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	0.10400950170692358
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.00840336	0.10400950170692358
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.10400950170692358
MICROFORM HOLOPROSENCEPHALY	0.00840336	0.10400950170692358
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.00840336	0.10400950170692358
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.10400950170692358
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00835253	0.10338037205262304
RENPENNING SYNDROME 1; RENS1	0.007902300000000001	0.09780781560454654
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.0078125	0.09669634908957135
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.0078125	0.09669634908957135
BARDET-BIEDL SYNDROME 6; BBS6	0.0078125	0.09669634908957135
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.0078125	0.09669634908957135
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0078125	0.09669634908957135
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.0078125	0.09669634908957135
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.0078125	0.09669634908957135
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.0078125	0.09669634908957135
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.0078125	0.09669634908957135
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.0078125	0.09669634908957135
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.0078125	0.09669634908957135
WAHAB SYNDROME	0.0078125	0.09669634908957135
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.0078125	0.09669634908957135
BARTSOCAS-PAPAS SYNDROME; BPS	0.0078125	0.09669634908957135
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.0078125	0.09669634908957135
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.0078125	0.09669634908957135
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.0078125	0.09669634908957135
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.0078125	0.09669634908957135
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0078125	0.09669634908957135
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.0078125	0.09669634908957135
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.0078125	0.09669634908957135
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0078125	0.09669634908957135
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.0078125	0.09669634908957135
TUKEL SYNDROME	0.0078125	0.09669634908957135
CURRY-JONES SYNDROME	0.0078125	0.09669634908957135
BLOOM SYNDROME	0.0078125	0.09669634908957135
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.0078125	0.09669634908957135
OROFACIODIGITAL SYNDROME VIII; OFD8	0.0078125	0.09669634908957135
JOUBERT SYNDROME 17; JBTS17	0.0078125	0.09669634908957135
TERMINAL OSSEOUS DYSPLASIA; TOD	0.0078125	0.09669634908957135
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.0078125	0.09669634908957135
TEEBI-SHALTOUT SYNDROME; TBSH	0.0078125	0.09669634908957135
GRANGE SYNDROME	0.0078125	0.09669634908957135
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0078125	0.09669634908957135
CRANIOECTODERMAL DYSPLASIA 3	0.0078125	0.09669634908957135
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.0078125	0.09669634908957135
SUMMITT SYNDROME	0.0078125	0.09669634908957135
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0078125	0.09669634908957135
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.0078125	0.09669634908957135
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.0078125	0.09669634908957135
BARDET-BIEDL SYNDROME 1; BBS1	0.0078125	0.09669634908957135
GRANGE SYNDROME; GRNG	0.0078125	0.09669634908957135
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.0078125	0.09669634908957135
KBG SYNDROME	0.0078125	0.09669634908957135
MOEBIUS SYNDROME; MBS	0.0078125	0.09669634908957135
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.0078125	0.09669634908957135
BRACHYDACTYLY, TYPE B1	0.0078125	0.09669634908957135
ADAMS-OLIVER SYNDROME 6; AOS6	0.0078125	0.09669634908957135
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0078125	0.09669634908957135
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0078125	0.09669634908957135
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.0078125	0.09669634908957135
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.0078125	0.09669634908957135
BARDET-BIEDL SYNDROME 5; BBS5	0.0078125	0.09669634908957135
BARDET-BIEDL SYNDROME 4; BBS4	0.0078125	0.09669634908957135
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0078125	0.09669634908957135
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.0078125	0.09669634908957135
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.0078125	0.09669634908957135
CAMPTOBRACHYDACTYLY	0.0078125	0.09669634908957135
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.0078125	0.09669634908957135
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.0078125	0.09669634908957135
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.0078125	0.09669634908957135
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.0078125	0.09669634908957135
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.0078125	0.09669634908957135
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.00771553	0.09549613853325575
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0075575	0.09354018025528775
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.0075575	0.09354018025528775
CHÉDIAK-HIGASHI SYNDROME	0.0075216400000000004	0.09309633627725869
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00735294	0.09100831399355812
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00735294	0.09100831399355812
SYNDACTYLY TYPE 1	0.00735294	0.09100831399355812
PALLISTER-HALL SYNDROME	0.00735294	0.09100831399355812
SYNPOLYDACTYLY 2	0.00735294	0.09100831399355812
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.00735294	0.09100831399355812
SYNDACTYLY TYPE 4	0.00735294	0.09100831399355812
CURRY-JONES SYNDROME	0.00735294	0.09100831399355812
OROFACIODIGITAL SYNDROME VI	0.00735294	0.09100831399355812
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00735294	0.09100831399355812
BRACHYDACTYLY-SYNDACTYLY, ZHAO TYPE	0.00735294	0.09100831399355812
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.00735294	0.09100831399355812
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00735294	0.09100831399355812
SPLIT-HAND/FOOT MALFORMATION 6	0.00735294	0.09100831399355812
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00735294	0.09100831399355812
CRANE-HEISE SYNDROME	0.00735294	0.09100831399355812
19Q13.11 MICRODELETION SYNDROME	0.00735294	0.09100831399355812
LINEAR VERRUCOUS NEVUS SYNDROME	0.00735294	0.09100831399355812
ADULT SYNDROME	0.00735294	0.09100831399355812
APHALANGY-HEMIVERTEBRAE-UROGENITAL-INTESTINAL DYSGENESIS SYNDROME	0.00735294	0.09100831399355812
MICROPHTHALMIA WITH LIMB ANOMALIES	0.00735294	0.09100831399355812
3Q29 MICRODUPLICATION SYNDROME	0.00735294	0.09100831399355812
ZLOTOGORA-OGUR SYNDROME	0.00735294	0.09100831399355812
CENANI-LENZ SYNDROME	0.00735294	0.09100831399355812
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.00735294	0.09100831399355812
ACRO-RENAL-OCULAR SYNDROME	0.00735294	0.09100831399355812
DYSOSTOSIS WITH BRACHYDACTYLY	0.00735294	0.09100831399355812
OROFACIODIGITAL SYNDROME IX; OFD9	0.00735294	0.09100831399355812
14Q22Q23 MICRODELETION SYNDROME	0.00735294	0.09100831399355812
FEINGOLD SYNDROME	0.00735294	0.09100831399355812
NEVUS COMEDONICUS SYNDROME	0.00735294	0.09100831399355812
LIMB-MAMMARY SYNDROME	0.00735294	0.09100831399355812
JEUNE SYNDROME	0.00735294	0.09100831399355812
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.00735294	0.09100831399355812
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00735294	0.09100831399355812
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00735294	0.09100831399355812
PFEIFFER SYNDROME TYPE 3	0.00735294	0.09100831399355812
LAURIN-SANDROW SYNDROME	0.00735294	0.09100831399355812
OROFACIODIGITAL SYNDROME IV; OFD4	0.00735294	0.09100831399355812
CAMPTOBRACHYDACTYLY	0.00735294	0.09100831399355812
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00735294	0.09100831399355812
PFEIFFER SYNDROME TYPE 2	0.00735294	0.09100831399355812
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00735294	0.09100831399355812
PFEIFFER SYNDROME TYPE 1	0.00735294	0.09100831399355812
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.00735294	0.09100831399355812
14Q11.2 MICRODELETION SYNDROME	0.00735294	0.09100831399355812
JUBERG-HAYWARD SYNDROME	0.00735294	0.09100831399355812
8P23.1 DUPLICATION SYNDROME	0.00735294	0.09100831399355812
SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00735294	0.09100831399355812
URBAN-ROGERS-MEYER SYNDROME	0.00735294	0.09100831399355812
HYPEREKPLEXIA 1; HKPX1	0.00728555	0.0901742190220194
FRANK-TER HAAR SYNDROME	0.00728555	0.0901742190220194
LEPRECHAUNISM	0.00728555	0.0901742190220194
SHPRINTZEN-GOLDBERG SYNDROME	0.00728555	0.0901742190220194
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00728555	0.0901742190220194
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.00728555	0.0901742190220194
WRINKLY SKIN SYNDROME	0.00728555	0.0901742190220194
BRITTLE CORNEA SYNDROME 2; BCS2	0.00728555	0.0901742190220194
SCARF SYNDROME	0.00728555	0.0901742190220194
AUTOSOMAL DOMINANT CUTIS LAXA	0.00728555	0.0901742190220194
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.00728555	0.0901742190220194
CATEL-MANZKE SYNDROME; CATMANS	0.00728555	0.0901742190220194
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.00728555	0.0901742190220194
SIALIDOSIS TYPE 2	0.00728555	0.0901742190220194
HURLER SYNDROME	0.00728555	0.0901742190220194
OSTEOGENESIS IMPERFECTA	0.00728555	0.0901742190220194
DE BARSY SYNDROME	0.00728555	0.0901742190220194
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.00728555	0.0901742190220194
HYPEREKPLEXIA 4; HKPX4	0.00728555	0.0901742190220194
DISTAL MONOSOMY 3P	0.00728555	0.0901742190220194
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00728555	0.0901742190220194
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.00728555	0.0901742190220194
SCARF SYNDROME	0.00728555	0.0901742190220194
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00728555	0.0901742190220194
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00728555	0.0901742190220194
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00728555	0.0901742190220194
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.00728555	0.0901742190220194
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00728555	0.0901742190220194
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00728555	0.0901742190220194
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.00728555	0.0901742190220194
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00728555	0.0901742190220194
MUCOPOLYSACCHARIDOSIS TYPE 7	0.00728555	0.0901742190220194
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.00724969	0.08973037504399035
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.00724969	0.08973037504399035
OMODYSPLASIA 1; OMOD1	0.00724969	0.08973037504399035
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.00724969	0.08973037504399035
CHROMOSOME 16P13.3 DELETION SYNDROME	0.00724638	0.08968940673480809
NIEMANN-PICK DISEASE TYPE C	0.00724638	0.08968940673480809
SPONTANEOUS PERIODIC HYPOTHERMIA	0.00724638	0.08968940673480809
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.00724638	0.08968940673480809
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.00724638	0.08968940673480809
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00724638	0.08968940673480809
MACHADO-JOSEPH DISEASE TYPE 1	0.00724638	0.08968940673480809
MACHADO-JOSEPH DISEASE TYPE 3	0.00724638	0.08968940673480809
MACHADO-JOSEPH DISEASE TYPE 2	0.00724638	0.08968940673480809
NEURALGIC AMYOTROPHY	0.00724638	0.08968940673480809
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.00724638	0.08968940673480809
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.00724638	0.08968940673480809
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.00724638	0.08968940673480809
VICI SYNDROME	0.00724638	0.08968940673480809
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00724638	0.08968940673480809
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.00724638	0.08968940673480809
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.00724638	0.08968940673480809
LARYNGOTRACHEAL ANGIOMA	0.00724638	0.08968940673480809
CHROMOSOME 17P13.1 DELETION SYNDROME	0.00724638	0.08968940673480809
MILD CANAVAN DISEASE	0.00724638	0.08968940673480809
SEVERE CANAVAN DISEASE	0.00724638	0.08968940673480809
16Q24.3 MICRODELETION SYNDROME	0.00704225	0.08716286264013234
17Q12 MICRODELETION SYNDROME	0.00704225	0.08716286264013234
RING CHROMOSOME 13 SYNDROME	0.00704225	0.08716286264013234
CHIME SYNDROME	0.00704225	0.08716286264013234
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.00704225	0.08716286264013234
MACROCEPHALY/AUTISM SYNDROME	0.00704225	0.08716286264013234
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.00704225	0.08716286264013234
HYPERLEXIA	0.00704225	0.08716286264013234
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.00704225	0.08716286264013234
MENTAL RETARDATION, X-LINKED 9	0.00704225	0.08716286264013234
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.00704225	0.08716286264013234
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.00704225	0.08716286264013234
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.00704225	0.08716286264013234
AUSTRALIA ANTIGEN	0.00704225	0.08716286264013234
LEUKOCYTE ADHESION DEFICIENCY	0.00704225	0.08716286264013234
MENTAL RETARDATION, X-LINKED 88	0.00704225	0.08716286264013234
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.00704225	0.08716286264013234
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.00704225	0.08716286264013234
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.00704225	0.08716286264013234
NANCE-HORAN SYNDROME	0.00704225	0.08716286264013234
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.00704225	0.08716286264013234
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00704225	0.08716286264013234
MOEBIUS SYNDROME	0.00704225	0.08716286264013234
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.00704225	0.08716286264013234
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.00704225	0.08716286264013234
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.00704225	0.08716286264013234
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.00704225	0.08716286264013234
COWDEN SYNDROME	0.00704225	0.08716286264013234
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.00671141	0.08306801206313473
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.00671141	0.08306801206313473
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313473
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.00671141	0.08306801206313473
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00671141	0.08306801206313473
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.00671141	0.08306801206313473
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.00671141	0.08306801206313473
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313473
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.00671141	0.08306801206313473
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.00671141	0.08306801206313473
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00671141	0.08306801206313473
GRAFT VERSUS HOST DISEASE	0.00671141	0.08306801206313473
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.00671141	0.08306801206313473
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.00671141	0.08306801206313473
HENNEKAM-BEEMER SYNDROME	0.00671141	0.08306801206313473
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.00671141	0.08306801206313473
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.00671141	0.08306801206313473
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00671141	0.08306801206313473
POLYMYOCLONUS, INFANTILE	0.00671141	0.08306801206313473
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.00671141	0.08306801206313473
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.00671141	0.08306801206313473
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.00671141	0.08306801206313473
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.00671141	0.08306801206313473
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.00671141	0.08306801206313473
MENTAL RETARDATION, X-LINKED 107; MRX107	0.00671141	0.08306801206313473
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.00671141	0.08306801206313473
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.00671141	0.08306801206313473
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.00671141	0.08306801206313473
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.00671141	0.08306801206313473
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.00671141	0.08306801206313473
KRABBE DISEASE	0.00671141	0.08306801206313473
FOLATE MALABSORPTION, HEREDITARY	0.00671141	0.08306801206313473
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00671141	0.08306801206313473
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00671141	0.08306801206313473
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00671141	0.08306801206313473
BETA-THALASSEMIA	0.00671141	0.08306801206313473
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.00671141	0.08306801206313473
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00671141	0.08306801206313473
BEHCET SYNDROME	0.00671141	0.08306801206313473
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.00671141	0.08306801206313473
DOORS SYNDROME	0.00671141	0.08306801206313473
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.00671141	0.08306801206313473
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00671141	0.08306801206313473
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00671141	0.08306801206313473
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.00671141	0.08306801206313473
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.00671141	0.08306801206313473
HYPOPHOSPHATASIA, INFANTILE	0.00671141	0.08306801206313473
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00671141	0.08306801206313473
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.00671141	0.08306801206313473
HYPOPHOSPHATASIA	0.00671141	0.08306801206313473
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.00671141	0.08306801206313473
MENTAL RETARDATION, X-LINKED 82	0.00671141	0.08306801206313473
INFANTILE DYSTONIA-PARKINSONISM	0.00671141	0.08306801206313473
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.00671141	0.08306801206313473
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.00671141	0.08306801206313473
ARGININOSUCCINIC ACIDURIA	0.00671141	0.08306801206313473
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.00671141	0.08306801206313473
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.00671141	0.08306801206313473
JOUBERT SYNDROME 14	0.00671141	0.08306801206313473
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.00671141	0.08306801206313473
CITRULLINEMIA, CLASSIC	0.00671141	0.08306801206313473
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.00671141	0.08306801206313473
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.00671141	0.08306801206313473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.00671141	0.08306801206313473
AICARDI-GOUTIERES SYNDROME 7	0.00671141	0.08306801206313473
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.00671141	0.08306801206313473
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.00671141	0.08306801206313473
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00671141	0.08306801206313473
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.00671141	0.08306801206313473
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.00671141	0.08306801206313473
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.00671141	0.08306801206313473
AICARDI-GOUTIERES SYNDROME 5	0.00671141	0.08306801206313473
46,XY SEX REVERSAL 9; SRXY9	0.00671141	0.08306801206313473
COG4-CDG	0.00671141	0.08306801206313473
PTEN HAMARTOMA TUMOR SYNDROME	0.00671141	0.08306801206313473
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00671141	0.08306801206313473
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.00671141	0.08306801206313473
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.00671141	0.08306801206313473
COG5-CDG	0.00671141	0.08306801206313473
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.00671141	0.08306801206313473
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.00671141	0.08306801206313473
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.00671141	0.08306801206313473
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.00671141	0.08306801206313473
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.00671141	0.08306801206313473
DIPHALLIA	0.005988240000000001	0.07411724102043327
3C SYNDROME	0.005988240000000001	0.07411724102043327
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.005988240000000001	0.07411724102043327
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.005988240000000001	0.07411724102043327
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.005988240000000001	0.07411724102043327
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.005988240000000001	0.07411724102043327
OGDEN SYNDROME; OGDNS	0.005988240000000001	0.07411724102043327
SYNDROMIC DIARRHEA	0.005988240000000001	0.07411724102043327
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.005988240000000001	0.07411724102043327
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00549451	0.06800627930062603
CAMPOMELIA, CUMMING TYPE	0.00549451	0.06800627930062603
AXENFELD-RIEGER SYNDROME	0.00549451	0.06800627930062603
DUANE RETRACTION SYNDROME	0.00549451	0.06800627930062603
TRISOMY 18-LIKE SYNDROME	0.00549451	0.06800627930062603
LAURENCE-MOON SYNDROME	0.00549451	0.06800627930062603
ZIMMERMANN-LABAND SYNDROME	0.00549451	0.06800627930062603
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.00549451	0.06800627930062603
BOWEN-CONRADI SYNDROME	0.00549451	0.06800627930062603
BEEMER-ERTBRUGGEN SYNDROME	0.00549451	0.06800627930062603
LARYNX ATRESIA	0.00549451	0.06800627930062603
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00549451	0.06800627930062603
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.00549451	0.06800627930062603
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00549451	0.06800627930062603
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00549451	0.06800627930062603
MCDONOUGH SYNDROME	0.00549451	0.06800627930062603
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.00549451	0.06800627930062603
DISTAL TRISOMY 18Q	0.00549451	0.06800627930062603
HEART-HAND SYNDROME TYPE 2	0.00549451	0.06800627930062603
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00549451	0.06800627930062603
MOSAIC TRISOMY 14	0.00549451	0.06800627930062603
TRISOMY 12P	0.00549451	0.06800627930062603
JOUBERT SYNDROME WITH RENAL DEFECT	0.00549451	0.06800627930062603
NON-DISTAL TRISOMY 10Q	0.00549451	0.06800627930062603
HALLERMANN-STREIFF SYNDROME	0.00549451	0.06800627930062603
DISTAL MONOSOMY 10P	0.00549451	0.06800627930062603
15Q26 OVERGROWTH SYNDROME	0.00549451	0.06800627930062603
KALLMANN SYNDROME	0.00549451	0.06800627930062603
BARAITSER-WINTER SYNDROME 2; BRWS2	0.00549451	0.06800627930062603
MONOSOMY 13Q14	0.00549451	0.06800627930062603
MARSHALL-SMITH SYNDROME	0.00549451	0.06800627930062603
ERYTHROKERATODERMIA VARIABILIS	0.00549451	0.06800627930062603
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.00549451	0.06800627930062603
HOLZGREVE SYNDROME	0.00549451	0.06800627930062603
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.00549451	0.06800627930062603
SRD5A3-CDG	0.00549451	0.06800627930062603
ACQUIRED VON WILLEBRAND SYNDROME	0.00549451	0.06800627930062603
AUROCEPHALOSYNDACTYLY	0.00549451	0.06800627930062603
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.00549451	0.06800627930062603
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00549451	0.06800627930062603
CAMPOMELIC DYSPLASIA	0.00549451	0.06800627930062603
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.00549451	0.06800627930062603
FRONTONASAL DYSPLASIA	0.00549451	0.06800627930062603
THALIDOMIDE EMBRYOPATHY	0.00549451	0.06800627930062603
TRISOMY 4P	0.00549451	0.06800627930062603
TARP SYNDROME; TARPS	0.00549451	0.06800627930062603
CONGENITAL HEART DEFECT-ROUND FACE-DEVELOPMENTAL DELAY SYNDROME	0.00549451	0.06800627930062603
ACROCRANIOFACIAL DYSOSTOSIS	0.00549451	0.06800627930062603
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00549451	0.06800627930062603
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00549451	0.06800627930062603
ANTLEY-BIXLER SYNDROME	0.00549451	0.06800627930062603
FLOATING-HARBOR SYNDROME	0.00549451	0.06800627930062603
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00549451	0.06800627930062603
PHENYLKETONURIA	0.00549451	0.06800627930062603
6Q25 MICRODELETION SYNDROME	0.00549451	0.06800627930062603
CAT-EYE SYNDROME	0.00549451	0.06800627930062603
FACIOSCAPULOHUMERAL DYSTROPHY	0.00549451	0.06800627930062603
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00549451	0.06800627930062603
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.00549451	0.06800627930062603
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00549451	0.06800627930062603
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.00549451	0.06800627930062603
46,XY PARTIAL GONADAL DYSGENESIS	0.00549451	0.06800627930062603
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00549451	0.06800627930062603
CHST3-RELATED SKELETAL DYSPLASIA	0.00549451	0.06800627930062603
NEUROFACIODIGITORENAL SYNDROME	0.00549451	0.06800627930062603
MOSAIC TRISOMY 8	0.00549451	0.06800627930062603
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00549451	0.06800627930062603
RENAL AGENESIS, BILATERAL	0.00549451	0.06800627930062603
ACROFACIAL DYSOSTOSIS, RODRÍGUEZ TYPE	0.00549451	0.06800627930062603
OROFACIODIGITAL SYNDROME TYPE 4	0.00549451	0.06800627930062603
TETRASOMY X	0.00549451	0.06800627930062603
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.00546448	0.06763459400614155
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.00546448	0.06763459400614155
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00546448	0.06763459400614155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00546448	0.06763459400614155
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00546448	0.06763459400614155
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00546448	0.06763459400614155
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00546448	0.06763459400614155
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.00546448	0.06763459400614155
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.00546448	0.06763459400614155
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.00546448	0.06763459400614155
ATTENTION DEFICIT-HYPERACTIVITY DISORDER	0.00546448	0.06763459400614155
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00546448	0.06763459400614155
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.00546448	0.06763459400614155
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.00546448	0.06763459400614155
SPASTIC PARAPLEGIA TYPE 7	0.00546448	0.06763459400614155
LEGIUS SYNDROME	0.00546448	0.06763459400614155
MUENKE SYNDROME	0.00546448	0.06763459400614155
NIJMEGEN BREAKAGE SYNDROME	0.00546448	0.06763459400614155
MICROTIA	0.00546448	0.06763459400614155
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.00546448	0.06763459400614155
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.00546448	0.06763459400614155
19P13.13 MICRODELETION SYNDROME	0.00546448	0.06763459400614155
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.00546448	0.06763459400614155
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.00546448	0.06763459400614155
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT	0.00546448	0.06763459400614155
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.00546448	0.06763459400614155
MARDEN-WALKER SYNDROME	0.00546448	0.06763459400614155
IMMUNODEFICIENCY 61; IMD61	0.00546448	0.06763459400614155
SCLEROSTEOSIS 1; SOST1	0.00537634	0.06654367353142095
NEUROFIBROMATOSIS, TYPE II	0.00537634	0.06654367353142095
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.00537634	0.06654367353142095
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.00537634	0.06654367353142095
FAMILIAL THROMBOCYTOSIS	0.00537634	0.06654367353142095
TURCOT SYNDROME WITH POLYPOSIS	0.00537634	0.06654367353142095
CAMURATI-ENGELMANN DISEASE	0.00537634	0.06654367353142095
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00537634	0.06654367353142095
SNEDDON SYNDROME	0.00537634	0.06654367353142095
FUNCTIONING GONADOTROPIC ADENOMA	0.00537634	0.06654367353142095
TSH-SECRETING PITUITARY ADENOMA	0.00537634	0.06654367353142095
PONTIAC FEVER	0.00537634	0.06654367353142095
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00537634	0.06654367353142095
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00537634	0.06654367353142095
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00537634	0.06654367353142095
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.00537634	0.06654367353142095
RAT-BITE FEVER	0.00537634	0.06654367353142095
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.00537634	0.06654367353142095
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.00537634	0.06654367353142095
ROSAÏ-DORFMAN DISEASE	0.00537634	0.06654367353142095
RELAPSING FEVER	0.00537634	0.06654367353142095
SEVERE HEMOPHILIA A	0.00537634	0.06654367353142095
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.00537634	0.06654367353142095
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.00537634	0.06654367353142095
PROLACTINOMA	0.00537634	0.06654367353142095
LUJO HEMORRHAGIC FEVER	0.00537634	0.06654367353142095
CUTANEOUS MASTOCYTOMA	0.00537634	0.06654367353142095
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.00537634	0.06654367353142095
MAJEED SYNDROME	0.00537634	0.06654367353142095
LEPTOSPIROSIS	0.00537634	0.06654367353142095
MACULOPAPULAR CUTANEOUS MASTOCYTOSIS	0.00537634	0.06654367353142095
NON-FUNCTIONING PITUITARY ADENOMA	0.00537634	0.06654367353142095
COLD AGGLUTININ DISEASE	0.00537634	0.06654367353142095
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.00537634	0.06654367353142095
DEAFNESS, AUTOSOMAL DOMINANT 34, WITH OR WITHOUT INFLAMMATION; DFNA34	0.00537634	0.06654367353142095
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.00537634	0.06654367353142095
LASSA FEVER	0.00537634	0.06654367353142095
GRANULOMATOSIS WITH POLYANGIITIS	0.00537634	0.06654367353142095
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.00537634	0.06654367353142095
PAROXYSMAL COLD HEMOGLOBINURIA	0.00537634	0.06654367353142095
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00537634	0.06654367353142095
HYPER-IGD SYNDROME	0.00537634	0.06654367353142095
AMERICAN TRYPANOSOMIASIS	0.00537634	0.06654367353142095
ENAMEL HYPOPLASIA, CATARACTS, AND AQUEDUCTAL STENOSIS	0.00537634	0.06654367353142095
GLUTAMATE MONOSODIUM SENSITIVITY	0.00537634	0.06654367353142095
PRIMARY FAMILIAL POLYCYTHEMIA	0.00537634	0.06654367353142095
MYXOPAPILLARY EPENDYMOMA	0.00537634	0.06654367353142095
PITUICYTOMA	0.00537634	0.06654367353142095
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 1	0.00537634	0.06654367353142095
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00537634	0.06654367353142095
PRIMARY CILIARY DYSKINESIA	0.00537634	0.06654367353142095
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00537634	0.06654367353142095
HELLP SYNDROME	0.00537634	0.06654367353142095
CRANIOSYNOSTOSIS 2	0.00537634	0.06654367353142095
INTERNAL CAROTID AGENESIS	0.00537634	0.06654367353142095
HUGHES-STOVIN SYNDROME	0.00537634	0.06654367353142095
SYSTEMIC MASTOCYTOSIS	0.00537634	0.06654367353142095
HODGKIN LYMPHOMA	0.00537634	0.06654367353142095
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00537634	0.06654367353142095
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00537634	0.06654367353142095
THYMIC TUMOR	0.00537634	0.06654367353142095
PAPILLOMA OF CHOROID PLEXUS	0.00537634	0.06654367353142095
DENGUE FEVER	0.00537634	0.06654367353142095
PARKES WEBER SYNDROME	0.00537634	0.06654367353142095
AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.06654367353142095
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.00537634	0.06654367353142095
SECONDARY POLYCYTHEMIA	0.00537634	0.06654367353142095
POLYCYTHEMIA VERA	0.00537634	0.06654367353142095
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.00537634	0.06654367353142095
PINEOCYTOMA	0.00537634	0.06654367353142095
PAPILLARY TUMOR OF THE PINEAL REGION	0.00537634	0.06654367353142095
ADENOHYPOPHYSITIS	0.00537634	0.06654367353142095
PITUITARY CARCINOMA	0.00537634	0.06654367353142095
OPTIC PATHWAY GLIOMA	0.00537634	0.06654367353142095
PERINEURAL CYST	0.00537634	0.06654367353142095
LHERMITTE-DUCLOS DISEASE	0.00537634	0.06654367353142095
PARIETAL FORAMINA	0.00537634	0.06654367353142095
CARNEY TRIAD	0.00537634	0.06654367353142095
EBOLA HEMORRHAGIC FEVER	0.00537634	0.06654367353142095
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.00537634	0.06654367353142095
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00537634	0.06654367353142095
CROUZON DISEASE	0.00537634	0.06654367353142095
MARBURG HEMORRHAGIC FEVER	0.00537634	0.06654367353142095
SOLAR URTICARIA	0.00537634	0.06654367353142095
HYDROXYKYNURENINURIA	0.00537634	0.06654367353142095
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.00537634	0.06654367353142095
EPISODIC ATAXIA, TYPE 3	0.00537634	0.06654367353142095
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00537634	0.06654367353142095
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.00537634	0.06654367353142095
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00537634	0.06654367353142095
JUVENILE TEMPORAL ARTERITIS	0.00537634	0.06654367353142095
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.00537634	0.06654367353142095
MARSILI SYNDROME; MARSIS	0.00537634	0.06654367353142095
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.00537634	0.06654367353142095
EPISODIC ATAXIA, TYPE 1; EA1	0.00537634	0.06654367353142095
HEMANGIOBLASTOMA	0.00537634	0.06654367353142095
EPISODIC ATAXIA TYPE 1	0.00537634	0.06654367353142095
SOTOS SYNDROME 2	0.00492611	0.060971117083344434
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.00492611	0.060971117083344434
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.00492611	0.060971117083344434
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 25	0.00492611	0.060971117083344434
GENIOSPASM 1; GSM1	0.00492611	0.060971117083344434
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.00492611	0.060971117083344434
DYSTONIA-APHONIA SYNDROME	0.00492611	0.060971117083344434
LAMB-SHAFFER SYNDROME	0.00492611	0.060971117083344434
PANIC DISORDER 1	0.00492611	0.060971117083344434
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00492611	0.060971117083344434
CHILDHOOD-ONSET BENIGN CHOREA WITH STRIATAL INVOLVEMENT	0.00492611	0.060971117083344434
ALAZAMI SYNDROME; ALAZS	0.00492611	0.060971117083344434
MENTAL RETARDATION, X-LINKED 63	0.00492611	0.060971117083344434
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.00473934	0.05865944001205365
11P15.4 MICRODUPLICATION SYNDROME	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.00473934	0.05865944001205365
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00473934	0.05865944001205365
JUVENILE MYOCLONIC EPILEPSY	0.00473934	0.05865944001205365
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.00473934	0.05865944001205365
JAWAD SYNDROME	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.00473934	0.05865944001205365
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.00473934	0.05865944001205365
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00473934	0.05865944001205365
MENTAL RETARDATION, X-LINKED 102	0.00473934	0.05865944001205365
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.00473934	0.05865944001205365
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.00473934	0.05865944001205365
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.00473934	0.05865944001205365
LOWE OCULOCEREBRORENAL SYNDROME	0.00473934	0.05865944001205365
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.00473934	0.05865944001205365
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.00473934	0.05865944001205365
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00473934	0.05865944001205365
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.00473934	0.05865944001205365
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00473934	0.05865944001205365
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00473934	0.05865944001205365
WIEDEMANN-STEINER SYNDROME; WDSTS	0.00473934	0.05865944001205365
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.00473934	0.05865944001205365
X-LINKED INTELLECTUAL DISABILITY-ACROMEGALY-HYPERACTIVITY SYNDROME	0.00473934	0.05865944001205365
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.00473934	0.05865944001205365
MENTAL RETARDATION, X-LINKED 99	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.00473934	0.05865944001205365
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00473934	0.05865944001205365
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.00473934	0.05865944001205365
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.00473934	0.05865944001205365
PITT-HOPKINS SYNDROME	0.00473934	0.05865944001205365
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.00473934	0.05865944001205365
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.00473934	0.05865944001205365
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.00473934	0.05865944001205365
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.00473934	0.05865944001205365
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.00473934	0.05865944001205365
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00454545	0.0562596377560566
CHRONIC GRAFT VERSUS HOST DISEASE	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00454545	0.0562596377560566
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, CORNEAL, 1	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM VARIANT	0.00454545	0.0562596377560566
BLAU SYNDROME	0.00454545	0.0562596377560566
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00454545	0.0562596377560566
BRADYOPSIA	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY, MEESMANN	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY, POSTERIOR POLYMORPHOUS, 1	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 1; RCD1	0.00454545	0.0562596377560566
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.00454545	0.0562596377560566
ISOLATED CONGENITAL ALACRIMA	0.00454545	0.0562596377560566
ALACRIMA, CONGENITAL	0.00454545	0.0562596377560566
ECTODERMAL DYSPLASIA SYNDROME	0.00454545	0.0562596377560566
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00454545	0.0562596377560566
HERMANSKY-PUDLAK SYNDROME	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 2	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 4	0.00454545	0.0562596377560566
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.00454545	0.0562596377560566
NEOVASCULAR GLAUCOMA	0.00454545	0.0562596377560566
OLIGOCONE TRICHROMACY	0.00454545	0.0562596377560566
MACULAR CORNEAL DYSTROPHY	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, PATTERNED, 1; MDPT1	0.00454545	0.0562596377560566
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM	0.00454545	0.0562596377560566
SJÖGREN-LARSSON SYNDROME	0.00454545	0.0562596377560566
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00454545	0.0562596377560566
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00454545	0.0562596377560566
KERATOENDOTHELIITIS FUGAX HEREDITARIA; KEFH	0.00454545	0.0562596377560566
BOUCHER-NEUHAUSER SYNDROME	0.00454545	0.0562596377560566
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00454545	0.0562596377560566
CORNEAL FLECK DYSTROPHY	0.00454545	0.0562596377560566
ALSTROM SYNDROME; ALMS	0.00454545	0.0562596377560566
ECTODERMAL DYSPLASIA 15, HYPOHIDROTIC/HAIR TYPE; ECTD15	0.00454545	0.0562596377560566
MUCOLIPIDOSIS IV; ML4	0.00454545	0.0562596377560566
TYROSINEMIA TYPE 2	0.00454545	0.0562596377560566
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00454545	0.0562596377560566
ALACRIMA	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 72; RP72	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 21; CORD21	0.00454545	0.0562596377560566
ACHROMATOPSIA 7; ACHM7	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 5; CORD5	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 17	0.00454545	0.0562596377560566
KID SYNDROME	0.00454545	0.0562596377560566
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.00454545	0.0562596377560566
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00454545	0.0562596377560566
OCULAR ALBINISM	0.00454545	0.0562596377560566
IDIOPATHIC ANTERIOR UVEITIS	0.00454545	0.0562596377560566
REACTIVE ARTHRITIS	0.00454545	0.0562596377560566
ACHROMATOPSIA	0.00454545	0.0562596377560566
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1H; CSNB1H	0.00454545	0.0562596377560566
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00454545	0.0562596377560566
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 5	0.00454545	0.0562596377560566
BLUE CONE MONOCHROMACY; BCM	0.00454545	0.0562596377560566
AUTOINFLAMMATION WITH ARTHRITIS AND DYSKERATOSIS; AIADK	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 79	0.00454545	0.0562596377560566
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.00454545	0.0562596377560566
RETINAL DYSTROPHY WITH OR WITHOUT MACULAR STAPHYLOMA; RDMS	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 6; CORD6	0.00454545	0.0562596377560566
CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE II	0.00454545	0.0562596377560566
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.0562596377560566
MACULAR DYSTROPHY, VITELLIFORM, 3; VMD3	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 3B	0.00454545	0.0562596377560566
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 10	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 11; CORD11	0.00454545	0.0562596377560566
RETINAL CONE DYSTROPHY 4	0.00454545	0.0562596377560566
STEVENS-JOHNSON SYNDROME	0.00454545	0.0562596377560566
MICROPHTHALMIA, ISOLATED 5	0.00454545	0.0562596377560566
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00454545	0.0562596377560566
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00454545	0.0562596377560566
CONE DYSTROPHY 4	0.00454545	0.0562596377560566
CHOROIDAL DYSTROPHY, CENTRAL AREOLAR 2; CACD2	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 51; RP51	0.00454545	0.0562596377560566
CONE DYSTROPHY 3	0.00454545	0.0562596377560566
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.00454545	0.0562596377560566
LEBER CONGENITAL AMAUROSIS 16	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 16	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 8; CORD8	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY 17; CORD17	0.00454545	0.0562596377560566
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00454545	0.0562596377560566
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.00454545	0.0562596377560566
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.00454545	0.0562596377560566
RETINAL DYSTROPHY WITH INNER RETINAL DYSFUNCTION AND GANGLION CELL ABNORMALITIES; RDGCA	0.00454545	0.0562596377560566
RETINITIS PIGMENTOSA 25; RP25	0.00454545	0.0562596377560566
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00454545	0.0562596377560566
RETINITIS PUNCTATA ALBESCENS	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM TYPE 6	0.00454545	0.0562596377560566
BILATERAL ACUTE DEPIGMENTATION OF THE IRIS	0.00454545	0.0562596377560566
IRVAN SYNDROME	0.00454545	0.0562596377560566
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00454545	0.0562596377560566
MUCOLIPIDOSIS TYPE IV	0.00454545	0.0562596377560566
JALILI SYNDROME	0.00454545	0.0562596377560566
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00454545	0.0562596377560566
LEUKONYCHIA TOTALIS	0.00454545	0.0562596377560566
FLOTCH SYNDROME	0.00454545	0.0562596377560566
MICROTIA-EYE COLOBOMA-IMPERFORATION OF THE NASOLACRIMAL DUCT SYNDROME	0.00454545	0.0562596377560566
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00454545	0.0562596377560566
BLUE CONE MONOCHROMATISM	0.00454545	0.0562596377560566
COGAN SYNDROME	0.00454545	0.0562596377560566
BIRDSHOT CHORIORETINOPATHY	0.00454545	0.0562596377560566
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.00454545	0.0562596377560566
CONE ROD DYSTROPHY	0.00454545	0.0562596377560566
PROGRESSIVE CONE DYSTROPHY	0.00454545	0.0562596377560566
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00454545	0.0562596377560566
ICHTHYOTIC KERATODERMA, SPASTICITY, HYPOMYELINATION, AND DYSMORPHIC FACIAL FEATURES; IKSHD	0.00454545	0.0562596377560566
DE SANCTIS-CACCHIONE SYNDROME	0.00454545	0.0562596377560566
OCULOCUTANEOUS ALBINISM	0.00454545	0.0562596377560566
ALBINISM, OCULAR, TYPE I	0.00454545	0.0562596377560566
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00454545	0.0562596377560566
X-LINKED RECESSIVE OCULAR ALBINISM	0.00454545	0.0562596377560566
HIDROTIC ECTODERMAL DYSPLASIA	0.00454545	0.0562596377560566
AMOEBIC KERATITIS	0.00454545	0.0562596377560566
VERNAL KERATOCONJUNCTIVITIS	0.00454545	0.0562596377560566
SJOGREN-LARSSON SYNDROME; SLS	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00454545	0.0562596377560566
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00454545	0.0562596377560566
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00454545	0.0562596377560566
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00454545	0.0562596377560566
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.00444444	0.055009423583699785
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.00444444	0.055009423583699785
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00444444	0.055009423583699785
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00444444	0.055009423583699785
WOLFRAM SYNDROME 2; WFS2	0.00444444	0.055009423583699785
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00444444	0.055009423583699785
TRIMETHYLAMINURIA	0.00444444	0.055009423583699785
PRIMARY SCLEROSING CHOLANGITIS	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 8	0.00444444	0.055009423583699785
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 28	0.00444444	0.055009423583699785
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.00444444	0.055009423583699785
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00444444	0.055009423583699785
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00444444	0.055009423583699785
GLUCAGONOMA	0.00444444	0.055009423583699785
ACERULOPLASMINEMIA	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA 42	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00444444	0.055009423583699785
GAUCHER DISEASE	0.00444444	0.055009423583699785
SPINOCEREBELLAR ATAXIA TYPE 42	0.00444444	0.055009423583699785
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.00444444	0.055009423583699785
MITOCHONDRIAL DNA-RELATED PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.00444444	0.055009423583699785
MACS SYNDROME	0.0042734999999999995	0.05289367652278824
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0042734999999999995	0.05289367652278824
ROIFMAN-CHITAYAT SYNDROME	0.0042734999999999995	0.05289367652278824
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.05289367652278824
ZIMMERMANN-LABAND SYNDROME 1	0.0042734999999999995	0.05289367652278824
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0042734999999999995	0.05289367652278824
BRANCHIOSKELETOGENITAL SYNDROME	0.0042734999999999995	0.05289367652278824
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0042734999999999995	0.05289367652278824
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.0042734999999999995	0.05289367652278824
COHEN-GIBSON SYNDROME; COGIS	0.0042734999999999995	0.05289367652278824
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0042734999999999995	0.05289367652278824
IMMUNODEFICIENCY 49; IMD49	0.0042734999999999995	0.05289367652278824
MEIER-GORLIN SYNDROME 6; MGORS6	0.0042734999999999995	0.05289367652278824
PELGER-HUET ANOMALY; PHA	0.0042734999999999995	0.05289367652278824
SMITH-KINGSMORE SYNDROME; SKS	0.0042734999999999995	0.05289367652278824
ICF SYNDROME	0.0042734999999999995	0.05289367652278824
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0042734999999999995	0.05289367652278824
CRANIOFACIAL DYSSYNOSTOSIS	0.0042734999999999995	0.05289367652278824
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.0042734999999999995	0.05289367652278824
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.0042734999999999995	0.05289367652278824
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.0042734999999999995	0.05289367652278824
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0042734999999999995	0.05289367652278824
RIN2 SYNDROME	0.0042734999999999995	0.05289367652278824
PROGEROID SYNDROME, PETTY TYPE	0.0042734999999999995	0.05289367652278824
GAPO SYNDROME	0.0042734999999999995	0.05289367652278824
3MC SYNDROME	0.0042734999999999995	0.05289367652278824
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.0042734999999999995	0.05289367652278824
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0042734999999999995	0.05289367652278824
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.0042734999999999995	0.05289367652278824
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.05289367652278824
MONOSOMY 9Q22.3	0.0042734999999999995	0.05289367652278824
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0042734999999999995	0.05289367652278824
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0042734999999999995	0.05289367652278824
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0042734999999999995	0.05289367652278824
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0042734999999999995	0.05289367652278824
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0042734999999999995	0.05289367652278824
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.00301205	0.037280542499231156
ULNAR-MAMMARY SYNDROME; UMS	0.00301205	0.037280542499231156
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00301205	0.037280542499231156
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.00301205	0.037280542499231156
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00301205	0.037280542499231156
LAMBERT SYNDROME	0.00301205	0.037280542499231156
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00301205	0.037280542499231156
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.00301205	0.037280542499231156
RHINY	0.00301205	0.037280542499231156
RUVALCABA SYNDROME	0.00301205	0.037280542499231156
SIMOSA CRANIOFACIAL SYNDROME	0.00301205	0.037280542499231156
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.00301205	0.037280542499231156
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00301205	0.037280542499231156
LAMBERT SYNDROME	0.00301205	0.037280542499231156
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.00301205	0.037280542499231156
SHORT-LIMB SKELETAL DYSPLASIA WITH SEVERE COMBINED IMMUNODEFICIENCY	0.00301205	0.037280542499231156
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00301205	0.037280542499231156
FAMILIAL ARTICULAR HYPERMOBILITY SYNDROME	0.00301205	0.037280542499231156
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00301205	0.037280542499231156
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00301205	0.037280542499231156
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00301205	0.037280542499231156
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00301205	0.037280542499231156
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00301205	0.037280542499231156
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.00301205	0.037280542499231156
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.00301205	0.037280542499231156
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.00301205	0.037280542499231156
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00301205	0.037280542499231156
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.037280542499231156
OSTEOGLOSPHONIC DYSPLASIA	0.00301205	0.037280542499231156
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00301205	0.037280542499231156
HERNIA, DOUBLE INGUINAL	0.00301205	0.037280542499231156
OROFACIODIGITAL SYNDROME XVI; OFD16	0.00301205	0.037280542499231156
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.00301205	0.037280542499231156
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00301205	0.037280542499231156
ANTERIOR CUTANEOUS NERVE ENTRAPMENT SYNDROME	0.00301205	0.037280542499231156
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.00301205	0.037280542499231156
EXSTROPHY OF BLADDER	0.00301205	0.037280542499231156
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.00301205	0.037280542499231156
MUCOLIPIDOSIS TYPE III	0.00301205	0.037280542499231156
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00301205	0.037280542499231156
MICROSPHEROPHAKIA WITH HERNIA	0.00301205	0.037280542499231156
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00301205	0.037280542499231156
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00301205	0.037280542499231156
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.00301205	0.037280542499231156
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00301205	0.037280542499231156
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00301205	0.037280542499231156
WIDOW'S PEAK SYNDROME	0.00301205	0.037280542499231156
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, TYPE VI	0.00301205	0.037280542499231156
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00301205	0.037280542499231156
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.00301205	0.037280542499231156
DIAPHANOSPONDYLODYSOSTOSIS	0.00301205	0.037280542499231156
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.00301205	0.037280542499231156
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00301205	0.037280542499231156
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00301205	0.037280542499231156
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.00301205	0.037280542499231156
OSTEOGENESIS IMPERFECTA, TYPE X	0.00301205	0.037280542499231156
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.00301205	0.037280542499231156
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.00301205	0.037280542499231156
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.00301205	0.037280542499231156
INTELLECTUAL DISABILITY, WOLFF TYPE	0.00301205	0.037280542499231156
MORQUIO SYNDROME A	0.00301205	0.037280542499231156
268650 RUDIGER SYNDROME	0.00301205	0.037280542499231156
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.00301205	0.037280542499231156
MARDEN-WALKER SYNDROME	0.00301205	0.037280542499231156
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00301205	0.037280542499231156
GM1 GANGLIOSIDOSIS	0.00301205	0.037280542499231156
PERSISTENT MULLERIAN DUCT SYNDROME, TYPES I AND II	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00301205	0.037280542499231156
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00301205	0.037280542499231156
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00301205	0.037280542499231156
ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.037280542499231156
BRUCK SYNDROME 2	0.00301205	0.037280542499231156
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.00301205	0.037280542499231156
SPONDYLOCOSTAL DYSOSTOSIS WITH ANAL ATRESIA AND UROGENITAL ANOMALIES	0.00301205	0.037280542499231156
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.00301205	0.037280542499231156
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00301205	0.037280542499231156
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00301205	0.037280542499231156
SHORT SYNDROME	0.00301205	0.037280542499231156
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.00301205	0.037280542499231156
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.00301205	0.037280542499231156
SHORT SYNDROME	0.00301205	0.037280542499231156
NEURAMINIDASE DEFICIENCY	0.00301205	0.037280542499231156
EHLERS-DANLOS SYNDROME, AUTOSOMAL RECESSIVE, CARDIAC VALVULAR FORM	0.00301205	0.037280542499231156
17P13.3 MICRODUPLICATION SYNDROME	0.00301205	0.037280542499231156
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.00301205	0.037280542499231156
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00301205	0.037280542499231156
RUVALCABA SYNDROME	0.00301205	0.037280542499231156
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00301205	0.037280542499231156
NOONAN SYNDROME 11; NS11	0.00297619	0.036836698521202096
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.00297619	0.036836698521202096
THANATOPHORIC DYSPLASIA TYPE 1	0.00297619	0.036836698521202096
8P11.2 DELETION SYNDROME	0.00297619	0.036836698521202096
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00297619	0.036836698521202096
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00297619	0.036836698521202096
AORTIC VALVE DISEASE 3; AOVD3	0.00297619	0.036836698521202096
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.00297619	0.036836698521202096
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00297619	0.036836698521202096
OROTIC ACIDURIA	0.00297619	0.036836698521202096
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.036836698521202096
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00297619	0.036836698521202096
KAPUR-TORIELLO SYNDROME	0.00297619	0.036836698521202096
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00297619	0.036836698521202096
JOHANSON-BLIZZARD SYNDROME; JBS	0.00297619	0.036836698521202096
HYPOPLASTIC LEFT HEART SYNDROME	0.00297619	0.036836698521202096
MCKUSICK-KAUFMAN SYNDROME	0.00297619	0.036836698521202096
TRANSALDOLASE DEFICIENCY	0.00297619	0.036836698521202096
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.036836698521202096
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00297619	0.036836698521202096
JUVENILE POLYPOSIS OF INFANCY	0.00297619	0.036836698521202096
FAMILIAL CUTANEOUS COLLAGENOMA	0.00297619	0.036836698521202096
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00297619	0.036836698521202096
CATEL-MANZKE SYNDROME	0.00297619	0.036836698521202096
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00297619	0.036836698521202096
LETHAL KNIEST-LIKE DYSPLASIA	0.00297619	0.036836698521202096
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00297619	0.036836698521202096
ZECHI-CEIDE SYNDROME	0.00297619	0.036836698521202096
ALAGILLE SYNDROME 1; ALGS1	0.00297619	0.036836698521202096
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.00297619	0.036836698521202096
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.00297619	0.036836698521202096
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00297619	0.036836698521202096
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.00297619	0.036836698521202096
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.00297619	0.036836698521202096
MEGALENCEPHALY	0.00297619	0.036836698521202096
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00297619	0.036836698521202096
MCDONOUGH SYNDROME	0.00297619	0.036836698521202096
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.00297619	0.036836698521202096
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00297619	0.036836698521202096
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00297619	0.036836698521202096
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.00297619	0.036836698521202096
LYMPHATIC MALFORMATION 7; LMPHM7	0.00297619	0.036836698521202096
20P12.3 MICRODELETION SYNDROME	0.00297619	0.036836698521202096
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.00297619	0.036836698521202096
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.00297619	0.036836698521202096
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00297619	0.036836698521202096
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.00297619	0.036836698521202096
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.00297619	0.036836698521202096
SPONDYLOOCULAR SYNDROME; SOS	0.00297619	0.036836698521202096
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.00297619	0.036836698521202096
CONGENITAL PULMONARY VALVE STENOSIS	0.00297619	0.036836698521202096
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.00297619	0.036836698521202096
FRONTOOCULAR SYNDROME	0.00297619	0.036836698521202096
%300712 CRANIOFACIOSKELETAL SYNDROME	0.00297619	0.036836698521202096
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00297619	0.036836698521202096
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.00297619	0.036836698521202096
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00297619	0.036836698521202096
NOONAN SYNDROME 8; NS8	0.00297619	0.036836698521202096
THANATOPHORIC DYSPLASIA TYPE 2	0.00297619	0.036836698521202096
ELLIS-VAN CREVELD SYNDROME	0.00297619	0.036836698521202096
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.00297619	0.036836698521202096
OROFACIODIGITAL SYNDROME XIV; OFD14	0.00297619	0.036836698521202096
NOONAN SYNDROME 7; NS7	0.00297619	0.036836698521202096
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00297619	0.036836698521202096
EBSTEIN ANOMALY	0.00297619	0.036836698521202096
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.00297619	0.036836698521202096
ALAGILLE SYNDROME 2	0.00297619	0.036836698521202096
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.00297619	0.036836698521202096
NOONAN SYNDROME 3; NS3	0.00297619	0.036836698521202096
NOONAN SYNDROME 5; NS5	0.00297619	0.036836698521202096
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00297619	0.036836698521202096
611961 STEVENSON-CAREY SYNDROME	0.00297619	0.036836698521202096
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.00297619	0.036836698521202096
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.00297619	0.036836698521202096
DIAMOND-BLACKFAN ANEMIA 4	0.00297619	0.036836698521202096
KLIPPEL-TRÉNAUNAY SYNDROME	0.00297619	0.036836698521202096
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00297619	0.036836698521202096
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00297619	0.036836698521202096
ATRIAL SEPTAL DEFECT 5	0.00297619	0.036836698521202096
XK APROSENCEPHALY SYNDROME	0.00297619	0.036836698521202096
HADZISELIMOVIC SYNDROME	0.00297619	0.036836698521202096
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00297619	0.036836698521202096
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00297619	0.036836698521202096
BARDET-BIEDL SYNDROME 2	0.00297619	0.036836698521202096
PRUNE BELLY SYNDROME	0.00297619	0.036836698521202096
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00297619	0.036836698521202096
SHASHI-PENA SYNDROME; SHAPNS	0.00297619	0.036836698521202096
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.00297619	0.036836698521202096
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00297619	0.036836698521202096
DIAMOND-BLACKFAN ANEMIA 16	0.00297619	0.036836698521202096
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.00297619	0.036836698521202096
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00297619	0.036836698521202096
KABUKI SYNDROME 1	0.00297619	0.036836698521202096
JACOBSEN SYNDROME	0.00297619	0.036836698521202096
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00297619	0.036836698521202096
ALAGILLE SYNDROME	0.00297619	0.036836698521202096
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00297619	0.036836698521202096
RECOMBINANT 8 SYNDROME	0.00297619	0.036836698521202096
AL KAISSI SYNDROME; ALKAS	0.00297619	0.036836698521202096
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.00297619	0.036836698521202096
THANATOPHORIC DYSPLASIA	0.00297619	0.036836698521202096
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00297619	0.036836698521202096
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00297619	0.036836698521202096
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.036836698521202096
WAARDENBURG SYNDROME TYPE 3	0.00297619	0.036836698521202096
SIFRIM-HITZ-WEISS SYNDROME	0.00297619	0.036836698521202096
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.00297619	0.036836698521202096
COFFIN-SIRIS SYNDROME 5	0.00297619	0.036836698521202096
GENITOPATELLAR SYNDROME	0.00297619	0.036836698521202096
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.00297619	0.036836698521202096
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00297619	0.036836698521202096
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.00297619	0.036836698521202096
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.00297619	0.036836698521202096
RECOMBINANT CHROMOSOME 8 SYNDROME	0.00297619	0.036836698521202096
CONGENITAL RUBELLA SYNDROME	0.00297619	0.036836698521202096
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00297619	0.036836698521202096
ELLIS VAN CREVELD SYNDROME	0.00297619	0.036836698521202096
TARP SYNDROME	0.00297619	0.036836698521202096
OCULOECTODERMAL SYNDROME; OES	0.00297619	0.036836698521202096
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.00297619	0.036836698521202096
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.00297619	0.036836698521202096
LYMPHEDEMA, HEREDITARY, III	0.00297619	0.036836698521202096
OCULODENTODIGITAL DYSPLASIA; ODDD	0.00297619	0.036836698521202096
CHROMOSOME 15Q14 DELETION SYNDROME	0.00297619	0.036836698521202096
PENILE AGENESIS	0.00297619	0.036836698521202096
FETAL TRIMETHADIONE SYNDROME	0.00297619	0.036836698521202096
